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ABSTRACT
Inflammatory cytokines play a significant role in the pathogenesis of obesity-related
diseases and have been implicated as integral factors in both early and late phases of
atherosclerosis. Lifestyle modifications such as increasing physical activity and making dietary
changes to induce weight loss are part of the primary prescription for the treatment of metabolic
syndrome. Additionally, physical activity has been implicated as a potentially effective regimen
for the control of inflammation, yet little is known about the anti-inflammatory mechanistic
alterations induced by physical activity.
Exercise training causes acute changes in inflammation immediately post exercise,
evidenced by upregulation of inflammatory cytokines and increased activity of leukocytes.
Production of inflammatory cytokines leads to increased circulating levels of monocytes and
macrophages as well as other immune cells. Additionally, chronic changes in inflammation occur
after recurring bouts of exercise, evidenced by upregulation and production of anti-inflammatory
cytokines and increased sensitivity of macrophages to stimuli. Previous publications from our
laboratory have found that whole blood samples from exercise trained individuals possess
significantly increased sensitivity to lipopolysaccharide (LPS) stimuli, resulting in lower levels
of interleukin-6 (IL-6), interleukin-1 beta (IL-1β), and tumor necrosis alpha (TNFα). Others have
also noted the decrease in circulating levels of inflammatory cytokines chronically with exercise
training.
The research presented in this dissertation is novel in that it explores the expression of the
melanocortin receptors (MCR) on the plasma membranes of systemic monocytes, indicating a
novel role for the MCRs as anti-inflammatory receptors that are regulated by chronic exercise
training. The melanocortin 1 receptor (MC1R), melanocortin 3 receptor (MC3R), and

xi

melanocrotin 5 receptors (MC5R) are expressed on immune cell populations. Several lines of in
vitro research have shown that activation of the MC3R on cultured macrophages leads to
upregulation of the anti-inflammatory pathways, suggesting a novel role for MCRs in mediating
exercise-induced inflammation. Here, I show that 12 weeks of resistance training in a young,
healthy population decreases both MC1R and MC3R receptor density on systemic monocytes in
conjunction with decreases in C-reactive protein (CRP). Furthermore, the percentage of
circulating monocytes expressing MC1R increases whiles those expressing MC3R decreases in
response to resistance training.
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CHAPTER 1. GENERAL INTRODUCTION
1.1 Inflammation and Macrophages
Inflammation has emerged as a focal point in the development of many diseases,
including obesity, type 2 diabetes (T2D), metabolic syndrome, and cardiovascular disease
(CVD), and is recognized as a potential causative agent and side effect of atherosclerosis and
insulin resistance [1-5]. Inflammation refers to the recruitment and activation of leukocytes, such
as macrophages to injured areas of the body as well as upregulation and increased secretion of
pro-inflammatory cytokines, such as interleukin-6 (IL-6), interleukin-1 beta (IL-1β), and tumor
necrosis factor alpha (TNFα) [1-2]. Recent investigations examining the etiology of
inflammatory associated diseases show that chronic inflammation, evidenced by activation of
immune cells such as monocytes and macrophages, can augment the onset of such diseases [1-5].
Additionally, pro-inflammatory cytokine serum concentrations, as well as concentrations within
various tissue microenvironments, are significantly elevated in several disease states [3-4].
Studying leukocytes, specifically monocyte and macrophage populations, is essential for
understanding immune abnormalities associated with chronic inflammatory disease states.
Monocyte and macrophage populations are key leukocytes responsible for the local
production of a variety of pro-inflammatory and anti-inflammatory cytokines that play an
important immunomodulatory role in the body [6-9]. Systemic, circulating monocytes are some
of the first responders to tissue damage within the body and are large contributors to proinflammatory cytokine production, including IL-6, TNFα, and IL-1β, during times of
inflammation. Conversely, monocytes and macrophages help alleviate inflammation by secreting
anti-inflammatory cytokines, such as IL-10 [1-2]. Anti-inflammatory cytokines provide negative
feedback in both autocrine and paracrine manners by inhibiting further production of proinflammatory cytokines from monocytes as well as other leukocytes. Shifts in macrophage
1

activation from a pro-inflammatory to an anti-inflammatory state may ameliorate the effects of
chronic inflammation and slow the progression of related diseases.
1.2 Effects of Exercise on Inflammation
Exercise training has been used as a successful intervention in changing inflammatory
profiles in several populations, including populations afflicted with obesity, T2D, and CVD [1013]. A large body of evidence supports the role of exercise training in decreasing chronic
inflammation [13-22]; yet, the mechanisms involved in creating these favorable changes remain
elusive. The lack of a consensus on the underlying mechanisms responsible for exercise-induced
decreases in chronic inflammation may be partially due to the high variation in exercise training
regimens utilized during intervention studies, as studies indicate that modality, intensity, and
duration may impact changes in inflammatory profiles. The degree of metabolic demand and the
level of fatigue are major contributors to changes in cytokine production that may be linked to
complex interactions between hormonal changes, metabolic by-products, motor unit recruitment,
myofibrillar disruption, and increases in body temperature [23-25]. Several lines of research
support the theory that metabolic changes in conjunction with muscle damage are responsible for
exercise-induced inflammation [23-29]. For example, high levels of IL-6 are found in
conjunction with glycogen depletion [26]. Evidence also shows a positive correlation between
lactate levels and IL-6 in young male wrestlers [27] as well as between muscle soreness and IL-6
[24, 28]. Furthermore, recruitment of larger muscle groups during an exercise bout leads to
larger numbers of circulating leukocytes afterwards [29-30]; and high intensity exercise (≥ 75%
VO2max) leads to secretion of IL-1 and IL-6 more so than moderate or low intensity exercise
[29-30]. Other causes of change observed in acute systemic cytokine levels following an exercise
bout may also be explained by blood redistribution following the exercise bout [31]. While
strenuous exercise leads to a redistribution of blood flow away from the splanchnic organs and to
2

contracting muscle, less strenuous exercise allows for normal blood flow to the splanchnic,
including renal blood flow [32]. Additionally, cytokine production with strenuous exercise may
show a larger systemic increase due to less clearance through urinary output, as previous studies
show that cytokines are removed in the urine following an exercise bout [33]. Thus, the
increased circulating time for inflammatory cytokine clearance during strenuous exercise may
cause the larger downstream adaptation to anti-inflammatory cytokine production.
In addition to the regulatory processes involved in immune response adaptations to acute
and chronic exercise, the physiological changes that occur in response to chronic exercise that
also contribute to changes in the inflammatory profile remain unknown. Exploration of the
regulatory pathways that may be modified by exercise training is convoluted by differences in
the length, intensity, duration, and modality of the exercise regimens prescribed. Despite these
differences, the strength of varying protocols is that an overall consensus still develops in the
realm of exercise science, as several investigations utilizing differing interventions have noted
changes in the inflammatory profile in response to exercise training [14-15, 21-23, 25, 28, 3439]. Interactions of metabolic demand, fatigue, and muscle damage may also contribute to
physiological adaptations present after chronic, repeated bouts of resistance training and may be
the most crucial factor in contributing to changes in inflammatory cytokine production, as
dramatic physiological changes in muscle have been noted after the first few resistance training
bouts [40]. It is possible that the effects of chronic exercise training may cause adaptations of the
immune response to occur due to repeated acute upregulation of pro-inflammatory cytokines that
may desensitize leukocytes to these cytokines [38]. Conversely, it is my hypothesis that there
may be no desensitization but rather leukocyte sensitization to pro-inflammatory cytokines in
response to chronic exercise, leading to a faster or more efficient response of the antiinflammatory pathways to stimuli. This action may eventually result in a blunted response,
3

where TNFα and other pro-inflammatory cytokines are acutely depressed after an exercise bout
in trained individuals compared to untrained individuals. Despite immense variation in exercise
training protocols, significant advances have been made in recent years towards identifying
possible regulatory processes involved in chronic inflammation through leukocyte stimulation
[13, 16, 18-19, 41-42]. Specifically, advances in the study of exercise training’s effects on
systemic monocytes have largely been made by identifying extracellular receptors that regulate
pro-inflammatory pathways and secretion of pro-inflammatory cytokines from monocytes [1819].
Interestingly, there are no studies exploring the possible identification of plasma
membrane receptors that regulate anti-inflammatory pathways and secretion of antiinflammatory cytokines from monocytes as a consequence of resistance exercise training. This
section will focus on the effects of exercise training on circulating markers of inflammation that
are known to regulate inflammation.
1.2.1. Acute Exercise and Inflammation
Exercise training causes acute changes in inflammation immediately post exercise,
evidenced by upregulation of inflammatory cytokines and increased activity of monocytes and
macrophages [1-2]. Specifically, heavy resistance training has been shown to acutely upregulate
systemic inflammatory cytokines and increase circulating levels of monocytes and other immune
cells [15, 17, 20-22, 25, 27, 30, 43-46].
IL-6: IL-6 is a major pro-inflammatory cytokine studied in the area of exercise
physiology. IL-6 is involved in the signaling cascade activated acutely after exercise training that
leads to upregulation of other pro-inflammatory cytokines and acute phase proteins, including
CRP. In addition to recruiting other immune cells to the area of damage, IL-6 and IL-1β are also
known to regulate the synthesis of CRP [47-49]. Specifically, IL-6 can regulate transcription of
4

CRP by increasing CCAAT/enhancer binding protein beta (C/EBPβ) binding to the C/EBP
binding site centered at position -53 on the CRP promoter [47, 50].
CRP: Due to its high correlation with the development of atherosclerosis and CVD,
measurement of CRP levels have become increasingly popular in establishing risk of myocardial
infarction and may serve as a more reliable and accurate marker of chronic inflammation than
pro-inflammatory cytokines [51-58]. Thus, CRP is rising in importance in medical communities
as a global marker of inflammation that may be as reliable as measuring blood cholesterol high
density lipoproteins and low density lipoproteins in an effort to determine health status [57].
1.2.2 Chronic Exercise and Inflammation
Contrary to the acute manifestations of exercise, chronic, recurring bouts of exercise lead
to an overall decrease in inflammation, evidenced by decreased recruitment of leukocytes into
the circulation as well as increased sensitization of macrophages to inflammatory stimuli. Studies
suggest that after repeated bouts of exercise, neutrophil recruitment to damaged muscle is
attenuated by 10-45% and inflammatory response receptor presentation is altered [23].
Recruitment of leukocytes may be largely dependent on beta adrenergic receptor (β-AR)
stimulation on circulating leukocytes by catecholamines, as blockade of the β2-AR by
propanolol ameliorates recruitment of monocytes and lymphocytes acutely post exercise [59-60].
Furthermore, catecholamine stimulation decreases whole blood levels of TNFα and IL-1β and
increases secretion of IL-10 from macrophages [42, 61-62]. Thus, a viable hypothesis of
exercise-mediated decreases in chronic inflammation may be that the transient increases in
catecholamine and pro-inflammatory cytokine release seen acutely, leads to activation of
monocyte plasma receptors and anti-inflammatory pathways effectively dowregulating proinflammatory cytokine production. Indeed, chronic changes in inflammation occur after
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recurring bouts of exercise, evidenced by increased anti-inflammatory cytokines, such as IL-10,
in circulation and increased sensitivity of macrophages to stimuli [15].
IL-10: IL-10 is considered an anti-inflammatory cytokine due to its ability to inhibit the
release of the inflammatory cytokines from monocytes and macrophages, including IL-6 [8]. IL10 works to decrease inflammation through activation of the JAK-STAT signaling pathway.
Briefly, IL-10 binds its receptor on the plasma membrane of the monocyte, activating the
tyrosine kinases, janus kinase 2 (Jak2) and tyrosine kinase 2 (Tyk2). Jak2 and Tyk2 then
phosphorylate the signal transducers and activators of transcription (STAT1, STAT2, and
STAT5) and help regulate gene expression. IL-10 acts in an anti-inflammatory manner by
inhibiting pro-inflammatory responses through inhibition of nuclear factor-kappa B (NF-kB)
[63].
1.3 Melanocortin 1 Receptor and Melanocortin 3 Receptor
Physical activity is known to create favorable changes in the cytokine profile of
individuals and is a viable treatment for slowing the progression and preventing the onset of
associated low-grade inflammatory diseases [10, 13, 15-16, 18, 41]. Although physical activity
is known to decrease circulating inflammatory cytokine levels, the mechanism behind these
changes remains unknown. With the recent finding that stimulation of melanocortin 3 receptors
(MC3R) on immune cells leads to upregulation of anti-inflammatory cytokine production,
MC3R activation provides a potential mechanism for exercise-induced changes in cytokine
profiles [41, 64-65]. MCRs are G-protein coupled transmembrane receptors that act through Gs
(stimulatory G protein) to increase cAMP [66]. There are 5 known melanocortin receptors,
MC1R through MC5R, whose roles are diverse and global in the body. Thus, while the finding
that MC3R activation on macrophages upregulates IL-10, two other melanocortin receptors,
melanocortin 1 receptor (MC1R) and melanocortin 5 receptors (MC5R), are also found on
6

immune cells and the MC1R may support the role of MC3R in its anti-inflammatory effects,
although MC5R does not appear to play a role in immunomodulation on monocytes [6-7, 6668]. This section will focus on specific MCRs and their regulation of the immune response
within monocyte and macrophage populations.
1.3.1 Melanocortin 1 Receptor
MC1R and MC3R have been shown to have redundant immunomodulatory roles within
macrophage cell lines. MC1R activation by agonist, including pro-opiomelanocortin peptide
(POMC)

cleavage

products

alpha

melanocortin

stimulating

hormone

(α-MSH)

or

adrenocorticotrophic hormone (ACTH), leads to upregulation and secretion of IL-10 [69-70].
MC1R is thought to increase anti-inflammatory actions through downregulating cluster of
differentiation 86 (CD86) expression on monocytes [69], a co-stimulatory protein that leads to
secretion of cytokines and activation of immune cells.
1.3.2 Melanocortin 3 Receptor
Like MC1R, activation of the MC3R by agonist, alpha melanocortin stimulating hormone
(α-MSH) or adrenocorticotrophic hormone (ACTH), causes secretion of IL-10 [71]. Studies have
shown that exercise increases levels of ACTH acutely which then acts on the adrenal cortex to
cause secretion of cortisol, a stress response hormone, but the ACTH response is blunted with
exercise training [72]. Acute increases in ACTH may have significant implications for the
present project since it may activate MC1R or MC3R on systemic monocytes, leading to
secretion of anti-inflammatory cytokines, such as IL-10, that then inhibit IL-6, TNFα, and IL-1β
secretion [6, 8, 41, 71, 73]. Indeed, activation of the MC3R on macrophages is known to inhibit
IL-6 and TNFα secretion [8, 71, 73-75].
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1.3.3 Research Focus
Overall the goal of this research project is to analyze changes in protein expression and to
determine how modifications to monocyte function can contribute to chronic inflammation and
associated disease states, such as CVD, obesity, and T2D. Specifically, I will examine the role of
resistance training in modulating anti-inflammatory receptors on the plasma membrane of
systemic monocytes. The work included in this dissertation explores a novel role for the MC1R
and MC3R in regulating anti-inflammatory processes associated with chronic exercise training.
The specific aims for the project are as follows.
Specific Aim 1: Hypothesis: MC1R and MC3R expression and density on plasma membranes
of circulating monocytes changes in response to chronic, repeated resistance training bouts.
Objectives:
A. Determine if MC1R cell surface expression on systemic monocytes changes in
response to resistance training.
B. Determine if MC3R cell surface expression on systemic monocytes changes in
response to resistance training.
Specific Aim 2: Hypothesis: Resistance training will alter CRP levels in conjunction with
changes in pro and anti-inflammatory cytokine profiles in college aged individuals.

Objectives:
A. Determine whether resistance training induces a change in CRP levels.
B. Determine whether resistance training induces changes in representative systemic
pro-inflammatory cytokines.
C. Determine whether resistance training induces changes in a representative systemic
anti-inflammatory cytokine.
8

Specific Aim 3: Hypothesis: MC1R or MC3R expression correlates to changes in the
inflammatory profile in college-aged individuals in response to resistance training.
Objectives:
A. Correlate resistance-training induced changes in MC1R on immune cells and specific
monocyte populations in whole blood with changes in markers of inflammation.
B. Correlate resistance-training induced changes in MC3R on immune cells and specific
monocyte populations in whole blood with changes in markers of inflammation.
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CHAPTER 2. LITERATURE REVIEW
2.1 Introduction
Impaired energy homeostasis leads to obesity, a low grade inflammatory state that
precedes metabolic syndrome and its associated diseases, such as T2D, CVD, and atherosclerosis
[76]. Currently, more than half of all U.S. adults are overweight or obese. Metabolic syndrome,
itself, is generally characterized by dyslipidemia, hypertension, insulin resistance, and obesity
and was estimated to affect 76 million people in the United States alone in 2007 [77]. Recent
investigations examining the etiology of obesity-related diseases show that chronic
inflammation, evidenced by activation of immune cells such as monocytes and macrophages, can
be a determinant in the onset of obesity [1-5]. In addition, macrophages are responsible for the
local production of a variety of cytokines, including the inflammatory cytokines IL-1β, IL-6, and
TNFα as well as anti-inflammatory cytokines, such as IL-10 [6-9]. These cytokines play an
immunomodulatory role in the development of obesity, and serum levels of IL-6, IL-1β, and
TNFα, as well as levels within various tissue microenvironments, are significantly elevated in
metabolic syndrome [3-4]. Physical activity is known to create favorable changes in the
inflammatory profile of individuals and is a viable treatment for slowing the progression and
preventing the onset of metabolic syndrome, T2D, CVD, and atherosclerosis [10, 13, 15-16, 18,
41]. Consequently, lifestyle modifications such as increasing physical activity and making
dietary changes to induce weight loss constitute the primary prescription for the treatment of
metabolic syndrome [78]. Even though physical activity has been implicated as a potentially
effective regimen for the control of inflammation, little is known about the anti-inflammatory
mechanistic alterations that occur with exercise.
Physical activity may affect inflammation through changes in cytokine expression in the
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central nervous system (CNS) as well as in peripheral tissues. Extensive research in the 1990s
has focused on the role of the CNS in the immune response, yet little attention has been paid to
how these effects manifest in the peripheral and tissue-specific immune response. Melanocortin
3 and 4 receptors (MC3R and MC4R, respectively) are G-protein coupled receptors that are
found in the CNS [79-81], peripheral tissues, and leukocytes [67, 82] and may act in mediating
the inflammatory response [7-8, 83-84]. Thus, the MCRs may play a crucial role in advancing
our knowledge of how the CNS communicates with the periphery in affecting inflammation.
Current research on the MC3R and MC4R focuses on their role in obesity, a disease state
associated with chronic inflammation [85-87]. More novel research on the MC3R has begun to
focus on understanding its role in the immune response. The most established model for MCR
activation is best understood in its regulation in a signaling cascade that controls adiposity and
satiation within the hypothalamus [85-88]. This model states that MCRs are activated in the
hypothalamus when leptin, secreted from adipocytes, binds leptin receptors on the proopiomelanocortin (POMC) neurons, causing the activation of POMC neurons and release of the
POMC polypeptide. Once translated, POMC is then proteolytically cleaved into various peptides,
including α-, β-, and γ- melanocyte-stimulating hormone (MSH), and adrenocorticotropic
hormone (ACTH). In the hypothalamus, ACTH, γ-MSH, or α-MSH (cleaved from ACTH) can
bind to the MCR, acting as an activating agonist [83, 89-90].
In other independent studies involving the culture of macrophages, studies show that
activation of the MC3R on macrophages can occur by subjecting the cells to media containing
either cyclic α-MSH (MT-II) or ACTH1-39. Once activated, there is an increase in IL-10 found
in the cell-free supernatant from the macrophages [91]. IL-10 is known for its effects as an
anti-inflammatory cytokine, inhibiting pro-inflammatory cytokine (IL-6, TNFα, and IL-1β)
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secretion from macrophages [15, 62, 74, 84]. ACTH production, itself, can be induced by IL-1β.
IL-1β is one of several pro-inflammatory cytokines secreted by macrophages during the acute
phase inflammatory response. IL-1β is also known to activate corticotrophin-releasing hormone
(CRH) neurons in the paraventricular nucleus (PVN) located in the hypothalamus [89]. PVN
neurons project to the hypophyseal portal system and noradrenergic neurons in the brainstem and
POMC neurons in the hypothalamus. Induction of CRH neurons leads to activation of the POMC
neurons that secrete α-MSH and ACTH which may lead to increased activation of MC3R in the
hypothalamus as well as in peripheral systemic macrophages [92]. Thus, with the recent finding
that immune cells possess MC3Rs and stimulation of the MC3R with agonist leads to
upregulation of anti-inflammatory cytokine production from macrophages, the MC3R provides a
potential mechanistic link for exercise-induced changes in cytokine profiles [41, 64-65].
2.2 Pro-inflammatory and Anti-inflammatory Response
2.2.1 Inflammation and Macrophages
Inflammation involves several physiological responses of the body to tissue/cellular
damage or infection, may be specific or nonspecific, and may be beneficial or harmful in specific
situations. The nonspecific inflammatory response is induced by infection or injury, resulting in
vasodilation and increased blood flow to the injured/infected area, increased infiltration of bodily
fluids into intracellular spaces, and increased number of leukocytes, such as neutrophils,
lymphocytes, and monocytes, in the area [93]. Responses are dependent on the presence of
adhesion molecules and inflammatory mediators, such as prostaglandins, histamine, and
serotonin [94]. Additionally, pro- and anti-inflammatory cytokines are chemical signals that play
a role in recruiting leukocytes to the area of injury. Leukocytes are defined as white blood cells
or derivations of hematopoietic stem cells from the bone marrow and are found in several
lymphoid tissues as well as the blood and lymph circulation. Leukocytes are broadly classified
12

into two groups; granulocytes, containing granules within the cytoplasm, and agranulocytes,
without granules in the cytoplasm. Within these classifications, leukocyte populations can be
subdivided into five different types. Granulocytes include neutrophils, basophils, and
eosinophils. Agranulocytes include lymphocytes and monocytes. As part of the acute cellular
response to injury, neutrophils are the first line of defense, followed by lymphocytes and
monocytes as part of the chronic cellular response when sufficient damage or infection occurs
[95].
As the immune system is extensive in its responses to infection/injury and involves the
communication and function of various cell types, it is impractical to review all immune
responses. Thus, the focus of this review will be on monocyte/macrophage responses and
populations, because they large producers of inflammatory cytokines that are widely studied in
response to exercise training within the peripheral circulation. Monocytes are the immature form
of macrophages that exist in the vascular endothelium and, in small fractions, in circulating
blood. Monocytes make up 10-15% of the circulating leukocyte population and primarily
function in phagocytosis, antigen presentation, cytokine production, and cytotoxicity [96-98].
There are several different factors involving various signaling cascades that induce maturation of
bone marrow derived monocytes into macrophages upon stimulation, including induction by
autocrine, paracrine, and endocrine cytokines. Maturation requires several steps; hematopoietic
stem cell to myeloid stem cell to monoblast to promonocyte to monocyte in the bone marrow and
then monocyte in the blood vessel [99]. During the various stages of differentiation, monocytes
express different cell surface proteins with specific receptor or adhesion molecule functions
[100]. Chemoattractants lead to upregulation of adhesion molecules on the cell surface of
circulating monocytes and signal through the various cell surface receptors to recruit derived and
differentiated monocytes to an injured tissue [101]. Adhesion molecules allow the binding of
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monocytes to endothelial cells for movement of the monocytes into the tissue. In addition, the
immune response leads to vasodilation, effectively slowing blood flow and monocyte movement
through the injured/infected area to allow for better recruitment [100]. Thus, monocytes are
allowed to move through diapedesis into the affected tissue, where they will then differentiate
into macrophages. Different stages of differentiation and combinations of cell surface protein
expression help determine the function of the monocyte/macrophage within the immune
response [100]. For example, monocytes express membrane-bound co-stimulatory molecule
recetpors, such as CD14 that acts as a receptor in the recognition of gram negative bacteria [102103]. Additionally, CD11a, CD25, CD35, CD45RO, and CD45RA are found on the cell surface
of circulating monocytes [96, 98, 100]. Once monocytes travel to the site of injury, they
differentiate into activated macrophages that remain viable for varying periods of time, lasting up
to several months. Macrophages also express several cell surface proteins that are used in their
identification and classification, separate from those of monocytes. Macrophages are known to
express CD11a, CD16, and CD45RO [96, 98, 100]. CD14 and CD16, a mediator of
phagocytosis, are the most widely used markers in the exercise literature for the recognition and
differentiation between monocyte and macrophage populations [102-103]. Heterogeneous
populations of macrophages exist within injured/infected tissues and are maintained by continual
influx from the circulation as well as local proliferation [102]. Fully differentiated macrophages
create a signaling cascade that induces recruitment of other leukocytes to the site of injury and
continue to regulate the inflammatory response as well as play a role in angiogenesis [104-105].
Chemical signals produced from macrophages include: bioactive lipids (prostaglandins,
prostacyclins, thromboxans, leukotrienes), glutathione, complement components, clotting
factors, proteinases (elastase, collagenase, angiotensin convertase, stromelysin), protease
inhibitors, peptidases, lipases, ribonucleases, heat shock proteins, apolipoprotein E, and
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cytokines (IL-1, IL-6, IL-8, TNFα, interferon γ (IFNγ), macrophage inflammatory proteins,
regulatory growth factors) [99]. Due to the secretion of various cytokines and other recruiting
factors, macrophages are part of the nonspecific cell-mediated immune response. Although they
may use antibody receptors such as CD receptors to recognize pathogens, macrophages are not
considered part of the humoral immune response, as they do not secrete antibodies in response to
antigens in order to neutralize the antigen [106].
2.2.2 Cytokines: IL-6 and IL-10
Pro- and anti-inflammatory cytokines help maintain inflammatory homeostasis [15, 62,
74, 84]. Inflammation is tightly regulated, as injury / infection requires a quick response in the
form of physiological changes at the site of injury / infection as well as a quick reversion of the
response to its former physiological state. An inability to revert leads to chronic inflammation
generally associated with several disease states [1-5]. Thus, cytokines are soluble intercellular
regulatory proteins that play a critical role in mediating the inflammatory response by acting as
paracrine, endocrine, or autocrine hormones. Cytokines are secreted by leukocytes, as well as
tissues such as muscle, and bind extracellular receptors on target cells to induce activation of
second messenger systems, leading to specific gene transcription [107]. Pro-inflammatory
cytokines are generally acute phase stimulants that signal to the hypothalamus to increase body
temperature through the production of prostaglandins of group E (PGE2) as well as acting to
alter metabolism and gene regulation within tissues such as the liver [99]. Pyrogenic proinflammatory cytokines include: IL-1β, IL-6, and TNFα.
IL-6: IL-6 is both a cytokine and myokine, meaning it’s released from immune cells and
myocytes [41, 108]. Its role in the inflammatory response is, at best, controversial. In myocytes,
it is known to correlate with energy mobilization and body temperature [109]. IL-6 acts by
binding cytokine receptors that activate the Janus kinase-signal transducers and activators of
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transcription (JAK-STAT) pathway [110]. The IL-6 receptor is a homodimer found within the
plasma membrane in which each protein possesses a single-pass transmembrane [111].
Activation of the receptor activates associated JAK molecules that in turn phoshorylate the
cytokine receptor [111], Phosphorylation of the cytokine receptor recruits proteins containing
phosphotyrosine-binding Scr homology 2 (SH2) domains, such as STATs. Recruited STATs are
also phosphorylated by JAK molecules at the site of the receptor, forming a scaffold for the
binding and phosphorylation of additional STATs [110]. STATs form homodimers that
translocate to the nucleus and act as transcription factors. Negative regulation of cytokine
receptors occurs by inhibiting STAT phosphorylation, involving suppressors of cytokine
signaling (SOCS), mechanically blocking activated STAT at the promoter region by protein
inhibitors of activated STATs (PIAS), or by dephosphorylation of cytokine receptors and STATs
by protein tyrosine phosphates [110].
IL-10: Upregulation of the pro-inflammatory cytokines leads to significantly increased
circulating numbers of monocytes, lymphocytes, and granulocytes [41-42] and a subsequent
induction and upregulation of anti-inflammatory cytokines. IL-10 is an anti-inflammatory
cytokine that acts to inhibit the release of the inflammatory cytokines, TNFα, IL-6, and IL-1β,
from monocytes and macrophages [8] as well as block neutrophil activation [99], thus alleviating
inflammation at the site of injury / infection. Once IL-10 binds its receptor, the JAK-STAT
signaling pathway is activated. Jak2 and Tyk2, both tyrosine kinases, are activated and
phoshporylate the transcription factors STAT1, STAT2, and STAT5, ultimately controlling gene
expression. IL-10 is thought to inhibit pro-inflammatory responses of the cell by inhibiting NFkB activity [63].

16

2.2.3 Acute Phase Protein: CRP
CRP is an acute phase protein secreted mainly by the liver in response to inflammatory
stimuli as part of the acute phase reaction within the immune system [112]. CRP is known to
bind to low density lipoprotein (LDL), at type of cholesterol that is increased in atherosclerosis,
and thus CRP plays a role in atherogenesis [113]. Large chronic increases in plasma CRP levels
are now commonly used as a marker of inflammation and as a possible risk factor for CVD
[113]. Upregulation of CRP production and secretion from hepatocytes is dependent on the
presence of the pro-inflammatory cytokine, IL-6 [114]. IL-6 may be released from systemic
immune cells, including monocytes and macrophages, and upregulates transcription factors, such
as C/EBPβ, that are needed for CRP transcription [115]. Regulation of IL-6 levels may also lead
to regulation of CRP levels at the transcriptional level. Additionally, measure of CRP plasma
levels may be a better indicator of inflammation in resting plasma samples due to its persistent
upregulation during chronic inflammation, unlike more transient cytokines such as IL-6 or IL-10
measurements in plasma, whose levels appear to be more transient in nature.
2.2.4 Pro-inflammatory Cytokines and the CNS Connection in the Periphery
Intercommunication between the nervous system and the lymphatic tissues exists, where
the CNS, particularly the hypothalamus-pituitary-adrenocortical axis (HPA), controls the
immune and inflammatory responses through the use of complex pathways involving
electrochemical signals [83, 89, 116]. This interconnecting web of pathways has been
demonstrated in many publications using lipopolysaccharide (LPS), a protein found on the outer
membrane of gram-negative bacteria, to mimic bacterial infection and immunostimulation [83,
89, 117]. Whole body responses to LPS include release of IL-1β and TNFα from macrophages
and, consequently, an increase in T-lymphocyte cell activation [118-119]. T-lymphocytes then
secrete IL-6, increasing the number of activated macrophages, leading to increased secretion of
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pro-inflammatory cytokines [120]. Furthermore, studies show that IL-1β, TNFα, and IL-6 are all
potent stimulators of the HPA axis. When rats are injected intracranially or peripherally
(subcutaneous) with LPS, there is an acute upregulation of plasma ACTH and corticosterone
levels and pro-inflammatory TNFα, IL-6, and IL-1β protein levels [83, 89]. This same response
can be seen in human whole blood samples exposed to LPS [62]. The existing data suggest that
the first pro-inflammatory responder to LPS is TNFα followed by IL-1β and IL-6. Chronic
stimulation with LPS leads to attenuation of ACTH and corticosterone circulating plasma levels
with chronically upregulated circulating IL-1β levels but not IL-6 or TNFα [83, 89]. The chronic
hypersecretion of IL-1β seen with LPS injection creates a blunted and short-lived acute response
of rats to LPS injection [83]. It has also been shown that a reciprocal pathway between the HPA
and periphery occurs, where stimulation of neurons with IL-1β, TNFα, or IL-6 leads to secretion
of corticotrophin-releasing hormone (CRH) and, subsequently, ACTH [84]. Similar
inflammatory responses occur within the systemic circulation and CNS in response to LPS
stimulation.
2.2.5 Anti-inflammatory Cytokine IL-10 in the Periphery and CNS
Interleukin 10 is an anti-inflammatory cytokine produced by macrophages in response to
LPS stimulation. IL-10 is referred to as an anti-inflammatory cytokine because it acts to inhibit
the release of the pro-inflammatory cytokines, TNFα, IL-6, and IL-1β, from monocytes and
macrophages [8]. Peripheral administration of IL-10 in rats causes inhibition of IL-1β secretion
in response to LPS stimulation in the brain stem and periphery but not the hypothalamus [9].
Conversely, central administration of IL-10 causes inhibition of IL-1β secretion in response to
LPS stimulation in the hypothalamus and brain stem but not in the periphery [9]. This suggests a
major role of IL-10 in subduing activation of the HPA axis in response to pro-inflammatory
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cytokines, where pro-inflammatory cytokines, such as IL-1β, in the periphery cause activation of
the HPA and secretion of corticotrophin-releasing factor (CRF), ACTH, and POMC.
2.3: Melanocortin Receptors in the Central Nervous System
2.3.1 Melanocortin Receptors are G Protein Coupled Receptors
Melanocortin receptors belong to a family of intramembrane receptors known as G
protein coupled receptors (GPCRs). GPCRs possess 7 transmembrane domains, with an
extracellular ligand binding site and an intracellular carboxy terminus linked to a G protein
[121]. Activation of the receptor occurs when ligand binds and the associated G protein is
activated. G proteins exist as heterodimers consisting of three separate subunits; Gα, Gβ, and Gγ
[122]. Over twenty different isoforms of Gα subunit can be found in mammalians, all of which
bind to guanine nucleotides, both guanine diphosphate (GDP) and triphosphate (GTP) [122]. In
the case of MCRs, Gαs (s meaning stimulatory) is the isoform activated when ligand binds to the
receptor. Gαs, formerly associated with GDP, undergoes an allosteric change that allows GTP to
replace GDP in the guanine nucleotide binding site and Gαs dissociates from Gβ and Gγ. Gαs
plus GTP then activate the enzyme, adenylyl cyclase [123]. GTP is hydrolyzed to GDP by the
GTPase activity of Gαs and adenylyl cyclase converts ATP to cyclic AMP (cAMP) [124]. The
now inactive Gαs associates with the Gβ and Gγ subunits again, the receptor is phosphorylated to
reduce its response to ligand [125]. cAMP is a second messenger that causes amplification of the
ligand’s effect on the cell by activating cAMP response element binding factor (CREB) and
protein kinase A (PKA) [126]. CREB is a transcription factor that binds to the nucleic acid
sequence 5’-TGACGTCA-3’ within the promoter region of various genes causing their
subsequent upregulation [65].
In addition to the upregulation of the cAMP second messenger system, evidence exists to
suggest that activation of several MCRs (MC2R and MC3R) by ligand activates other second
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messenger systems involving inositol phosphate (IP3) and intracellular calcium (Ca) [127].
Upregulation of the IP3 / Ca second messenger is indirectly related to upregulation of cAMP
production in agonist-stimulated MC3R transfected cells. PKA is a negative regulator of IP3 /
Ca, thus induction of MCR and subsequent increases in intracellular cAMP, leading to
concominant increases in PKA, may be the regulatory pathway controlling inhibition of IP3 / Ca
upregulation after MCR stimulation [127]. The third transmembrane domain of MCR is thought
to be the regulatory loop of the receptor that couples to the necessary G protein, conferring
upregulation of specific, separate second messenger systems [127]. One explanation for the
dependence of the specific systems is a post translation modification, such as phosphorylation of
the third transmembrane loop. Increases in PKA may lead to phosphorylation of the regulatory
domain of MCR, changing the conformation of the protein and leading to the binding of different
G protein subunits with subsequent upregulation of separate second messenger systems.
2.3.2 Melanocortin Receptors and Metabolism: MC3R and MC4R
The brain is the most complex organ of the body and is involved in many functions,
including intercepting and interpreting endocrine signals from other organs. Specifically, the
hypothalamus is considered the central unit of satiety comprehension and metabolic signaling
[80, 85, 128-130]. The brain is a major player in the battle against obesity and T2D. It is known
from extensive research on the arcuate nucleus (ARC) and lateral hypothalamus that there are
specific neurons, POMC neurons, which receive endocrine signals from peripheral adipose tissue
in the form of hormones [80, 85, 128, 131]. Leptin is one such hormone which binds to receptors
located on the POMC neurons [80, 128, 131]. Leptin is an endocrine hormone secreted from
adipocytes, the circulating amount of which is directly dependent on the amount of adipose
tissue present. Leptin travels through the blood stream, crosses the blood brain barrier, and binds
to leptin receptors located on the plasma membrane of POMC neurons. Once bound, the protein
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POMC is released from the neurons and later proteolytically cleaved into various differing
peptides, including: ACTH, α, β, and γ-MSH [132]. ACTH, β-MSH, and α-MSH are all agonistic
peptides able to bind the melanocortin 3 (MCR3) and 4 (MCR4) receptors, located in the ARC,
lateral hypothalamus, dorsomedial hypothalamic nucleus (DMH), and the PVN of the
hypothalamus [79, 132]. The MC3R and MC4R are also under the control of agonistic
competition through the effects of agouti-related peptide (AgRP) and neuropeptide Y (NPY),
peptides also released by neurons in the hypothalamus and controlled by leptin expression [80,
85, 128-130]. When leptin is present in the brain and the MC3R and MC4R are bound by their
agonistic peptides, the sympathetic nervous system (SNS) is stimulated to release norepinephrine
(NE) leading to increased thermogenesis and energy expenditure as well as inhibition of food
intake [86, 133], positively correlating with an increase in lipolysis and fatty acid oxidation [134135]. When leptin is absent, AgRP binds to MC3R and MC4R, preventing agonists from binding
[136], whereas NPY binds to separate receptors located on the POMC neurons, antagonizing the
release of agonistic peptides [137]. Under antagonistic conditions, hyperphagia ensues, energy
expenditure decreases, and fatty acids are converted to triglycerides for storage in adipose tissue.
Although the pathway of leptin signaling in the brain seems complete, our understanding
of the mechanisms underlying the roles of MC3R and MC4R are not fully understood and the
distinct actions of each receptor with regards to nutrient sensing, satiety, and metabolism remain
to be elucidated. Thus, it becomes necessary to speak of both receptors when the role of one
receptor is being examined. Extensive studies have found that mice lacking the MC4R are
hyperphagic, eating as much as three times that as WT mice, hypometabolic, and exhibit
increased body weight as well as increased fat mass [87-88, 138-140]. MC3R knock out (KO)
mice also develop increased fat mass, although this occurs through a different mechanism than
that of MC4R KO mice. MC3R KO mice are not hyperphagic, hypometabolic, or overweight.
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Instead they exhibit differences in nutrient partitioning, where fat free mass (FFM) is sacrificed
in order to conserve and even increase fat mass (FM) [87-88, 139]. Furthermore, when injected
with leptin, MC4R KO mice exhibit ablation of hyperphagia with compromised SNS activation,
whereas MC3R KO mice show full activation of the SNS with failure of leptin to reduce food
intake [86]. When MC4R KO mice are fed a diet with moderate (7%) increases in fat, metabolic
efficiency is further exacerbated, leading to larger increases in adiposity [87, 141-143]. When
MC3R KO mice are fed a diet with moderate (7%) increases in fat they still do not exhibit
increases in body weight or become hyperphagic, although they do exhibit increases in adiposity
and metabolic efficiency [87, 141-143].
Thus, it is obvious that MC4R and MC3R are mediators not only in food intake and SNS
activation, but also in nutrient partitioning, and metabolic efficiency. The separate roles of each
remain to be completely elucidated, but it can be concluded that, generally, MC4R is used in the
comprehension of satiation and food intake, whereas the MC3R is mainly used in the
comprehension of nutrient composition of food and subsequently nutrient partitioning.
2.4. Melanocortin Receptors and the Immune Response
The immune response is greatly interconnected with various parameters of metabolism,
where metabolic pathways are highly regulated, independent of metabolic changes, during
inflammation. Disturbance in metabolic homeostasis can lead to hypoxia, decrease in
intracellular pH, release of lysosomal enzymes, disruption of cell membranes, and decreased
mitochondrial function. Dysfunctional mitochondria are the cause of impaired oxidative
phosphorylation and insufficient ATP production [144-146]. Cells must utilize anaerobic
respiratory pathways, glycogen, and creatine phosphate stores to create ATP for survival.
Depletion of glycogen and creatine phosphate rapidly occurs, leading to accumulation of
intracellular sodium and water in addition to potassium leakage [146]. Protein synthesis halts as
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a result of damaged endoplasmic reticulum and ribosomes. Calcium accumulates in the
mitochondria and necrosis of the cell occurs. This process is recognized by the body as cellular
damage and induces the inflammatory response [99]. The inability to maintain metabolic
homeostasis has been associated with infection and inflammation and is generally believed to be
the product of changes in cytokine expression rather than the initiators of changes in cytokine
expression. Therefore, researchers hypothesize that low level chronic inflammation may actually
precede the manifestation of several diseases, such as T2D, metabolic syndrome, and cancer.
2.4.1 Melanocortin Receptors and the Immune Response in the CNS: MC3R
The melanocortin system, meaning the POMC neurons and MCRs and their agonists and
antagonists, is one pathway that is highly regulated in the CNS to control metabolic homeostasis
as well as inflammation. It has been shown that LPS injections increase production of leptin from
peripheral adipose tissue and decreases food intake in hamsters. Futhermore, injections of TNFα
or IL-1 also increase secretion of leptin from epididymal white adipose tissue (EWAT) despite
decreases in food intake [147-148]. As stated previously, leptin is an endocrine hormone that
travels through the blood from peripheral adipose tissue to the brain, where is can bind leptin
receptors on POMC neurons, leading ultimately to activation of MC3R. In addition to increased
secretion of leptin from adipose tissue, intraperitoneal injections of human IL-1β in rats increase
plasma ACTH levels with a concomitant decrease in ACTH anterior pituitary levels, increases in
POMC mRNA in the anterior pituitary, and no difference in CRF in the hypothalamus [149]. It
has also been shown that CRF directly upregulates POMC expression in the anterior pituitary
[149]. In studies using the AtT-20 corticotroph tumor cell line, it has been shown that IL-6 and
Il-1β, but not TNFα, significantly upregulate ACTH secretion [150]. In the same study, by
luciferase assay, CRH increases POMC promoter activity. Promotor activity is also minimally
upregulated with TNFα, IL-6, or IL-1β, but when CRH is added along with either cytokine, the
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effects of CRH alone on POMC promoter activity are potentiated [150]. Thus, modulation of the
HPA axis during the immune response can be initiated by cytokines in the hypothalamus or
pituitary, causing activation of POMC neurons by leptin, transcription and secretion of POMC
by IL-6, IL-1β, TNFα and CRH, leading to increased ACTH secretion by protease activity of the
POMC peptide. Speculation leads to the conclusion that MC3R activation by ACTH or its
derivative peptide, α-MSH, in the HPA axis is important in mediating pro- and antiinflammatory responses as well as associated diseases, including obesity.
2.4.2 Melanocortin Receptors and the Immune Response in the Periphery: MC1R, MC3R,
and MC5R
The role of MCRs in the inflammatory response extends from the CNS to peripheral
tissues where MC3Rs are known to exist on granulocytes, lymphocyres, macrophages, and
monocytes [67, 82]. The inflammatory and metabolic pathways involving the MC3R in the CNS
is mimicked in these peripheral immune cells, especially macrophages. POMC is expressed in
lymphocytes subpopulations and monocytes [67]. POMC-derived ACTH, α-MSH, β-MSH, and
γ-MSH are also expressed within immune cells, including lymphocytes. Studies show that
activation of MC3R on macrophages by α-MSH or ACTH inhibits IL-6 and TNFα production in
macrophages [7, 75]. In human monocytes, there is an increase in α-MSH production in response
to IL-6 or TNFα stimulation [151]. Though macrophages are known to possess both MC1R and
MC3R, and both are activated by ACTH and α-MSH, recent studies indicate that MC1R or the
MC3R on macrophages are sufficient in mediating the peripheral anti-inflammatory response in
monocytes and macrophages while the function of MC5R on monocytes / macrophages remains
unknown [69-70].
Other recent studies have explored the role of MCRs in inflammation by using the MC4R
KO and MC3R KO mouse models. MC4R KO mice exhibit increased macrophage infiltration
into adipose tissue, a phenomenon normally associated with inflammation. In addition, when
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placed on a high fat diet where MC4R KO mice become extremely obese, macrophage
infiltration in adipose tissue is exacerbated and chronic inflammation ensues, leading to insulin
resistance [152-153]. On the other hand, MC3R KO mice only become obese when placed on a
high fat diet, yet an increase in macrophage number within the adipose tissue of obese MC3R
KO mice is not seen nor is an upregulation of TNFα mRNA [152-153]. One explanation is that
the MC3R presence on macrophages and within the CNS is crucial for the inflammatory
response to take place. Thus, it is clear that the role of MC3R in mediating the immune response
is necessary in the CNS as well as in peripheral tissues, and these pathways are intertwined.
In order to fully understand the biological mechanisms underlying the immune response
and how we can manipulate the response in order to help diseased individuals, it is necessary to
study the connections between the immune response in the CNS and periphery. Studies have
extensively shown that activation of the POMC neurons occurs during inflammation in response
to pro-inflammatory cytokines; IL-6, IL-1β, and TNFα [154-155]. This translates to increased
ACTH secretion in the hypothalamus [154]. Studies also show that circulating POMC and
ACTH levels are increased during inflammation [154-155]. In other independent studies, it is
known that macrophages, responders to stress and initiators of the immune response, possess
MC3Rs. MC3R are important in regulation of metabolic responses in the CNS. They are
activated by various derivatives of POMC, including ACTH, α-MSH, β-MSH, and γ-MSH, in
the hypothalamus. Furthermore, MC3Rs on cultured peritoneal macrophages show activation in
response to stress, mimicking the response of MC3R in the CNS. In response to activation at the
MC3R, macrophages secrete IL-10, an anti-inflammatory cytokine, which in turn inhibits
secretion of IL-6, IL-1β, and TNFα from macrophages. Additionally, activation of the MC1R on
macrophages shows a redundant role of these MCRs in mediating the anti-inflammatory
processes of macrophages. It remains unclear if the MC1R and MC3R may be activated in
25

response to different external stimuli or cause differential cellular processes to occur, as both
receptors are able to bind the same agonists and seem to elicit the same cellular responses.
Hence, research that focuses on the changes of MC1R and MC3R during acute and chronic
inflammation will help to elucidate the mechanisms behind MCR activation and their subsequent
effects on infection and disease, providing the necessary connection between peripheral and
central inflammatory pathways and disease prevention.
2.5 Effects of Exercise on the Immune System
2.5.1 Effects of Exercise on Inflammation Related Disease Development
Exercise is an easily controlled and utilized form of therapy for many diseases, such as
T2D, atherosclerosis, metabolic syndrome, and CVD. A major therapeutic effect of regular
exercise is its potential to decrease inflammation, as some of the most prominent diseases in
today’s society coincide or are preceded by the presence of chronic inflammation. For instance,
CVD is currently the leading cause of death in Western countries, accounting for approximately
40% of annual deaths in the United States. There are several forms of CVD; coronary heart
disease (CHD), cerebrovascular disease, hypertension, heart failure, and rheumatic heart disease.
The leader in deaths amongst the various forms of CVD is CHD, with CHD killing
approximately 445,687 deaths in 2005 alone [77]. Development of CHD involves
atherosclerosis, a buildup of plaque in the arteries that leads to luminal narrowing and decreased
compliance. Initiation of atherosclerosis begins with injury and endothelial dysfunction, causing
recruitment of leukocytes, specifically monocytes, to the area. Monocytes then migrate into the
intima of the vessel wall, where they mature into macrophages and begin endocytosis of low
density lipoprotein (LDL) cholesterol [156-157]. Once LDL cholesterol molecules are engulfed
by the macrophage, the cell is referred to as a foam cell. Foam cells remain present in the intima
chronically and increase in number over time. Eventually, the foam cells form plaque within the
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vessel walls. Atherosclerosis is initiated as an inflammatory response to injury of the vessel and
proceeds into chronic inflammation of the area [158]. Build up of plaque causes decreased
responsiveness of the vessel to stimuli that normally control dilation of the vessel and
compliance to changes in blood pressure [159]. Additionally, dislodging of the plaque from the
vessel wall into the circulation may cause vascular blockage and tissue ischemia, stroke, or
death. Because initiation of atherosclerosis is believed to be due to injury and subsequent
recruitment of monocytes as well as additional leukocytes to the area, CHD is largely controlled
by inflammatory cells and cytokines [57].
Whereas CHD is the number one killer of Americans, T2D was listed in 2005 as the
seventh leading cause of death in the United States. T2D may be correlated with CHD, as 68%
and 16% of the T2D deaths in 2005 in people aged 65 or older also exhibited heart disease and
stroke, respectively [160]. Additionally, 75% of those diagnosed with T2D also possess
hypertension. Given that CVD and T2D appear to afflict the same populations, it is no surprise
that T2D is also linked to chronic low-grade inflammation. Diabetics exhibit increased levels of
blood glycoproteins, acute phase proteins, and elevated leukocyte counts [161-163]. Elevated
cytokine levels themselves are thought to be a predictor of T2D [163]. Furthermore, elevated
levels of inflammatory cytokines are positively correlated with insulin resistance, the
distinguishing factor in type 2 diabetics. Also correlated with T2D is obesity, a major cause of
metabolic syndrome [164]. Obesity promotes inflammation in adipose tissue as well as the
circulation. It is thought that obesity-related inflammation can lead to insulin resistance and
further tissue damage in the pancreas [165]. Thus, obesity may be an underlying factor in the
etiology of T2D that creates a vicious cycle of chronic inflammation and insulin resistance.
Closely related to T2D, metabolic syndrome is a newly recognized disease that
encompasses several of the risk factors seen not only in T2D but also in CHD. Metabolic
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syndrome, also referred to as syndrome X or dysmetabolic syndrome, is characterized by
abdominal obesity, insulin resistance or glucose intolerance, hypertension, dyslipidemia, and,
most notably, inflammation. It was estimated that in 2007 approximately 76 million people in the
United States can be classified as having metabolic syndrome [77]. Coincidently, 44% of obese
adolescents develop metabolic syndrome [77]. One of the most highly associated factors of
metabolic syndrome is chronic inflammation. Sufferers of metabolic syndrome exhibit high
levels of circulating pro-inflammatory cytokines, including IL-6 and TNFα [166]. Because
obesity is a major contributing factor to metabolic syndrome, it is plausible that chronic
inflammation associated with metabolic syndrome is a direct result of increased adiposity.
Several researchers note an association between obesity and chronic inflammation, with some
hypothesizing that the pro-inflammatory state of adipose tissue is a precursor to obesity [166].
As some of the most prevalent diseases in today’s society all involve a state of low level
chronic inflammation, reduction in risk factors for these disease states all include increasing
physical activity. Indeed, a large body of evidence that shows an inverse relationship between
increased physical activity levels and decreased inflammation supports the anti-inflammatory
effects of exercise. Studies show that fitness level is a stronger predictor for death than smoking,
high cholesterol, and diabetes [167]. Notably, exercise alone can increase high density
lipoprotein (HDL) cholestrol and insulin sensitivity, improve body composition, and decrease
plasma triglycerides, cholesterol, blood pressure and inflammatory cytokines [13, 159, 168-169].
Studies show that those who take part in a regular exercise program have much lower incidence
of CHD than sedentary counterparts [167]. Additionally, development of CHD in physically
active populations, if it does occur, has been shown to be less severe and develop at a later age
[167]. Exercise promotes insulin independent uptake of glucose into working muscles, helping to
control plasma glucose levels [170]. As a result, tissues become more insulin sensitive over time
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[167]. Physical activity helps to alleviate insulin resistance in T2D and metabolic syndrome,
even allowing some diabetics to lower or stop taking medications related to these diseases.
Exercise decreases circulating levels of pro-inflammatory cytokines, such as those associated
with T2D, obesity, and metabolic syndrome [171-172]. Not only is exercise an excellent
therapeutic strategy to alleviate the development of a multitude of diseases, but it is also an
excellent model to use in the study of the immune response due to its ease of implementation and
few detrimental side effects.
2.5.2 Effects of Exercise on Pro and Anti-Inflammatory Cytokines in Peripheral Tissues
During exercise, there is tissue injury leading to inflammation. Thus, the effects of
exercise mimic the initiation of the immune response. During muscle contraction, IL-6 is
secreted from myocytes as well as systemic leukocytes. IL-6 is known to activate macrophages,
leading to secretion of IL-1β and TNFα. Secretion of IL-1β and TNFα recruit other immune cells
to the site of injury. The inflammation associated with exercise is generally referred to in two
separate phases, the acute and chronic phases. Acute changes in inflammation occur immediately
post exercise and can continue for over four hours after the completion of exercise [15]. Chronic
changes in inflammation can last for weeks or months after chronic, recurring exercise. The two
phases are distinctive from each other due mainly to the differences in cytokine expression.
During acute phase, local tissue injury causes upregulation of circulating and muscle specific
pro-inflammatory cytokines, including IL-6, IL-1β, and TNFα [15, 108]. Upregulation of the
pro-inflammatory cytokines in turn leads to significantly increased circulating levels of
macrophages, NK cells, monocytes, lymphocytes, granulocytes, T-helper, and T-cytotoxic cells
[41-42].

Acute exercise also induces increased activity of macrophages [42]. Mechanisms

underlying the acute increase in pro-inflammatory secretion observed following exercise can be
contributed to activation of the p38 mitogen activated protein kinase (MAPK) and nuclear factor29

Κβ (NF-Κβ) pathways [147]. MAPKs are serine / threonine kinases that are responsible for
controlling gene expression through phosphorylation of various proteins, including nitric oxide
synthase (NOS). NOS is responsible for producing NO, which has antimicrobial and tumoricidal
activity, in macrophages. NF-Κβ is a transcription factor responsible for enhancing NO
production in macrophages by enhancing transcription of NOS [173].
Generally, after chronic exercise, there is an increase in circulating levels of IL-10,
leading to decreased secretion of pro-inflammatory cytokines, IL-1α and TNFα [11]. There is
also increased sensitivity of macrophages to stimuli and increased levels of NO production [10].
Although there may also be an increase in IL-6 during chronic exercise, this may be due to the
fact that IL-6 is both a myokine (secreted by myocytes) and a cytokine. In fact, it has been
postulated that the production of IL-6 from muscle during exercise induces the secretion of IL10. IL-10 may then act to decrease circulating levels of IL-1β and TNFα [34].
2.5.3 Effects of Exercise on CRP
Several studies support the role of exercise in decreasing circulating CRP levels [38, 174177]. While studies utilizing aerobic exercise interventions show beneficial effects of exercise in
lowering body weight, adiposity, and increasing fitness, aerobic exercise has not been shown to
create the same level of favorable changes in CRP levels as resistance training [38, 174-177]. For
example, our lab, in conjunction with Dr. Tim Church’s lab at Pennington Biomedical Research
Center, has shown that 6 months of regular aerobic exercise at incremental doses of (50%, 100%,
and 150%) of the NIH Consensus Panel physical activity recommendation on cardiorespiratory
fitness failed to reduce CRP in healthy, overweight/obese postmenopausal women [37, 178].
Conversely, several independent studies have shown that resistance training significantly
decreases CRP levels, decreases IL-6 and IL-1β concentrations, increases the anti-inflammatory
cytokine IL-10, and induces overall alterations in chronic inflammation [39, 174-175]. Given
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that CRP is transcriptionally regulated by the presence of IL-6 [15, 47, 50], resistance training
induced alterations in CRP transcription and translation may be aided by alterations in the proinflammatory cytokine, IL-6 as well as IL-1β. IL-6 and IL-1β production from monocyte /
macrophages is further negatively impacted by the synthesis and production of the antiinflammatory cytokine, IL-10 [15]. Thus, even in younger, healthy populations, it appears that
resistance training exerts the most beneficial effects on chronic inflammation by changing
circulating inflammatory cytokine profiles and inducing changes in global markers of
inflammation, such as CRP.
2.5.4 Effects of Exercise on Inflammation in the CNS
Given the relationship between the CNS and periphery in the inflammatory response, it’s
no surprise that exercise exerts its effects not only in peripheral tissues but also through signaling
pathways in the CNS. Exercise, like IL-1β, activates CRH neurons in the hypothalamic PVN
[89]. PVN neurons in turn project to the hypophyseal portal system and noradrenergic neurons in
the brainstem and POMC neurons in the hypothalamus. Thus, induction of CRH neurons as a
result of exercise leads to the release of the neurotransmitters, NE and epinephrine (Epi), as well
as activation of the POMC neurons that secrete α-MSH and ACTH. Exercise also causes an
increase in MC3R mRNA in the hypothalamus [179]. In the periphery, NE inhibits TNFα and
IL-6 production through activation of beta adrenergic receptors (β-AR) in human whole blood
extracts stimulated with LPS [62]. Studies also show that isoproteronol, a β-AR agonist, inhibits
TNFα but not IL-6 production after exercise [41-42]. Furthermore, it is known that muscle
secretes IL-6 in response to contraction. Thus, it appears that the peripheral changes seen during
exercise may stimulate the pathway associated with the immune response in the CNS, which in
turn may regulate peripheral inflammation during the acute and chronic phases of exercise.
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2.6 Immune Cell Response to Exercise
2.6.1 Population Response to Exercise
Acute bouts of exercise not only lead to an increase in inflammatory cytokine secretion
from leukocytes in the periphery, but also lead to acute leukocytosis, or increased leukocyte
recruitment into the circulation [14, 20]. The increases seen are proportionally related to the
intensity of the exercise bout [23]. It is believed that increases in circulating leukocytes are due
to increases in SNS stimulation, and leukocytosis is largely due to increases in NK cells and
neutrophils [14, 20-21, 25]. Muscle damage that occurs during an exercise bout, causing NK cell
and neutrophil recruitment, induces release of pro-inflammatory cytokines into the circulation
and recruitment of other leukocytes to the area. After the exercise bout, macrophages become the
predominant leukocyte type in the damaged muscle [180]. Furthermore, pro-inflammatory
cytokines are replaced by anti-inflammatory cytokines being released from the newly activated
macrophages. Macrophages may remain within the tissue, releasing cytokines, for up to fourteen
days after the exercise bout, whereas neutrophils are transiently recruited for up to twenty-four
hours after the exercise bout [29]. Studies report that activated neutrophils and macrophages
release the pro-inflammatory cytokines IL-1β and TNFα up to 5 days after an exercise bout [29].
These transient systemic increases in pro-inflammatory cytokines acutely after exercise may be
attributed to secretion from contracting myocytes instead of secretion from recruited leukocytes
[181]. Support for this hypothesis has been documented in several studies that reveal that acute
spontaneous cytokine production within circulating monocytes is not the source of increased
TNFa or IL-6, although these cytokines are significantly elevated in serum after exercise [21].
Transient increases in pro-inflammatory cytokines, whether initially produced from circulating
monocytes or contracting myocytes, lead to recruitment and activation of leukocyte
subpopulations, resulting in possible production and secretion of pro-inflammatory cytokines
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from monocytes. Furthermore, activation of monocytes by pro-inflammatory cytokines,
independent of their source of production, will result in changes in anti-inflammatory cytokine
production from activated monocytes. Evidence shows that, acutely, exercise simultaneously
upregulates circulating levels of pro-inflammatory cytokines as well as anti-inflammatory
cytokines and pro-inflammatory cytokine “inhibitors” [23, 25, 27, 29, 33]. The hypothesis of
simultaneous secretion is that muscle contraction leads to the production of the pro-inflammatory
cytokines, recruiting and activating leukocytes, which in turn produce and secrete antiinflammatory cytokines [29].
Contrary to the acute manifestations of exercise, chronic, recurring bouts of exercise
lead to an overall decrease in inflammation, evidenced by decreased recruitment of leukocytes
into the circulation as well as increased sensitization of macrophages to inflammatory stimuli
[17]. One of the first endocrine responses to an exercise bout is an increase in the secretion of
Epi and NE from the adrenal glands. Increases in SNS output help to increase heart rate, cardiac
output, oxygen uptake and metabolism and acts to maintain homeostasis of oxygen uptake to
carbon dioxide production, waste production to waste removal, and heat production to heat loss.
Chronic exercise training may lead to a desensitization of leukocytes by downregulation of
receptors, specifically β-ARs, the receptors responsible for responsiveness of leukocytes to SNS
activation [182]. Thus, chronic recurring bouts of exercise leads to attenuated recruitment of
certain leukocyte subpopulations into the circulation after an acute bout of exercise. It is
plausible that exercise exerts its anti-inflammatory effects, alleviating chronic inflammation, by
effectively decreasing leukocyte recruitment to inflamed areas. Indeed, studies suggest that after
repeated bouts of exercise, neutrophil recruitment to damaged muscle is attenuated by 10-45%
and inflammatory response receptor presentation is altered [29]. Recruitment of leukocytes may
be largely dependent on ß-AR stimulation by catecholamines, as blockade of the ß2-AR by
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antagonist ameliorates recruitment of monocytes and lymphocytes acutely post exercise [5960]. Furthermore, catecholamine stimulation decreases whole blood levels of TNFa and IL-1ß
and increases secretion of IL-10 from macrophages [61-62]. Another viable hypothesis of
exercise-mediated decreases in chronic inflammation may be that the transient increases in
catecholamine and pro-inflammatory cytokine release seen acutely leads to activation of
macrophage plasma receptors and anti-inflammatory pathways affectively dowregulating proinflammatory cytokine production.
2.6.2 Classically Activated vs. Alternatively Activated Macrophages vs. Type II Activated
Macrophages
Macrophages exert differential effects through activation of divergent pathways, pro- or
anti-inflammatory. Differential effects are a result of a complex hierarchy of macrophage
phenotypes, activation, and pathways. Currently, three macrophage phenotypes are recognized;
classically activated, alternatively activated, and type II activated macrophages. Classically
activated macrophages are characterized by Th1 type response to inflammation, meaning they
work to recruit other immune cells to the site of injury, release pro-inflammatory cytokines such
as interferon gamma (IFNγ), degrade extracellular matrices, and promote apoptosis [183-184].
Conversely, alternatively activated macrophages are characterized by a Th2 type response,
release anti-inflammatory cytokines such as IL-10, construct extracellular matrices, and
promote angiogenesis [184]. A critical balance between pro- and anti-inflammatory statuses is
maintained by the recruitment of differential macrophage phenotypes to an injured area [183].
Differentiation of macrophages into classically versus alternatively activated is
dependent on activation of priming pathways through binding of circulating proteins to plasma
receptors on the macrophages. IFNγ, once bound to IFNγ membrane receptors, is an adequate
priming factor for classically activated macrophages. After being primed macrophages then
commit to the classically activated pathways when challenged by inflammatory stimuli such as
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LPS. Classically activated macrophages are responsible for eliciting significant tissue damage
when unchecked by promoting degradation of tissue as well as promoting chronic inflammation
in the area. Alternatively activated macrophages are used by the body to balance the
inflammatory response, counteracting the effects of classically activated macrophages.
Alternatively activated macrophages release anti-inflammatory cytokines leading to prevention
of chronic inflammation and tissue destruction [184]. Alternatively activated macrophages do
not require priming before committing to the alternative pathway; instead circulating cytokines
interleukin 4 (IL-4), interleukin 13 (IL-13), or glucocorticoids seem to be sufficient in activating
alternative macrophages [184]. When activated, these macrophages also undergo morphological
changes, recruit leukocytes to the injured area, and secrete several factors involved in promoting
extracellular matrix construction as well as cell proliferation [183].
In addition to classically and alternatively activated macrophages, scientists now
recognize a third macrophage phenotype, the type II activated macrophage [184]. Type II
activated macrophages are characterized by altered cytokine release upon stimulation.
Stimulation causes downregulation of interleukin 12 (IL-12) and increased secretion of IL-10,
which in turn causes secretion of IL-4 from T cells. Activation of type II macrophages requires
ligation of the Fc receptors for immunoglobulin G (IgG) (FcγR) by antigen IgG complexes plus
inflammatory stimuli. Both unprimed and IFNγ primed macrophages may be stimulated to
express the type II activated phenotype. In response to stimulation, these macrophages mimic a
Th2 response, much like the alternatively activated macrophages [6, 184].
Response to Exercise
Changes seen in cytokine production from circulating macrophages in response an acute
versus chronic exercise may be due to differential macrophage phenotype. Studies have shown
that chronic resistance and aerobic exercise decrease IFNγ levels in whole blood samples [11,
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185]. Given that classically activated macrophages require priming by IFNγ for activation,
exercise may attenuate recruitment and stimulation of classically activated macrophages in
response to injury. This agrees with the literature that promotes exercise as a therapy for
decreasing chronic inflammation, as classically activated macrophages promote inflammation in
a Th1 manner [6]. Furthermore, decreases seen in circulating pro-inflammatory cytokines with
chronic exercise correlate with the hypothesis that long-term adherence to an exercise training
program may preferentially stimulate differential macrophage phenotypes within the circulation
[13]. Conversely, exercise may promote recruitment of the alternatively activated macrophage
phenotype into the circulation. Exercise has been shown to upregulate IL-4 and increase
endocrine glucocorticoids, notably cortisol [116, 186]. Both factors are sufficient to stimulate
the alternatively activated macrophage phenotype, possibly increasing levels of circulating antiinflammatory cytokines [187].
2.6.3 Macrophage Response to External Inflammatory Stimuli
Endotoxin, specifically LPS, is the most prevalent stimuli used to induce inflammation
through activation of the innate immune response in experimental research. LPS is a component
of gram negative bacteria and acts as an endotoxin to elicit an immune response. LPS is
composed of three main components; O polysaccharide, core antigen, and lipid A [117]. Lipid
A exists as a phosphorylated dimer of N-acetylglucosamine plus six or seven fatty acid chains
that functions as the anchoring region of LPS, conferring the toxicity of LPS to the host [188].
The O polysaccharide confers immunogenicity by binding to tissues. It varies largely in
structure amongst bacterial strains, with polysaccharide chains ranging in length and in structure
[189]. Once LPS is in the circulation, it promotes inflammation by binding to soluble LPS
binding protein (LBP) and soluble or CD14 [190]. CD14 delivers the LPS to the recognition site
of the LPS recognition complex on the plasma membrane of the leukocyte, composed of a toll
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like receptor (TLR) and lymphocyte antigen 96 (MD2) [191]. When inflammatory stimulus,
such as LPS, is recognized by macrophages, it causes phagocytosis and degradation of the
pathogen / pathogen component within the macrophage [192]. Morphological changes as well
as secretory changes occur, leading to recruitment of neutrophils, immature dendritic cells, NK
cells, and activated T cells to the site. LPS stimulated macrophages further recruit leukocytes
by secreting pro-inflammatory cytokines, including IL-1β, IL-6, and TNFα .
Whereas LPS creates a pro-inflammatory environment through activation of TLRs on
macrophages, β-ARs are known to be involved in creating an anti-inflammatory response when
activated on macrophages. Much like MCRs, β-ARs are GPCRs that activate G proteins,
activating the enzyme adenylate cyclase, resulting in formation of the transcriptional factor
cAMP. Three subtypes of β-AR have been identified; β1-AR, β2-AR, and β3-AR. All three
receptor subtypes can lead to activate of the G protein subtype, Gs (stimulatory) and increase
cAMP. Additionally, the β2-AR can also activate the Gi subtype (inhibitory), inhibiting increases
in cAMP. β-ARs can be stimulated by several agonists, including the catecholamines Epi and
NE. Varying β-AR subtypes can be localized to specific tissues throughout the body. Most
notably, the predominanat β-AR subtype on macrophages is the β2-AR. Catecholamines have
been shown to play a role in inflammation by inhibiting IL-6, IL-1, and TNFα production from
mononuclear cells, most likely through β-AR activation [193-194]. In addition, stimulation of
β2-ARs on whole blood leukocytes have been shown to attenuate LPS induction of TNFα
production and secretion [42, 195]. Catecholamines also decrease IL-1β secretion in whole blood
in response to LPS [62]. It is suggested that decreases in pro-inflammatory cytokine production
in whole blood by LPS stimulation preceded by catecholamine or β-AR agonist is mediated by
increases in IL-10, as IL-10 increases are seen after catecholamine stimulation [62].
Additionally, LPS stimulation of macrophages causes decreases in β2-AR in macrophages [196].
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Given the attenuation of inflammation normally associated with LPS treatment of macrophages
in cultures first stimulated with β-AR agonist, it appears that there may be cross talk between βARs on macrophages and TLRs. It is plausible that the anti-inflammatory effects of exercise are
partially mediated by elevated catecholamines during exercise, leading to increases in β-AR
activation on circulating macrophages, that in turn decreases the pro-inflammatory response to
muscle damage that normally induces activation of the TLRs and production and secretion of
pro-inflammatory cytokines.
Response to Exercise
Exercise creates direct and indirect adaptations of the immune system to inflammatory
stimuli. Several studies remark on the ability of chronic exercise to alter immunological
response. In addition to exogenous LPS derived from gram negative bacteria being used as an
initiator of inflammation in biological studies, endogenous LPS has also been shown to be
elevated within the circulation of endurance athletes after long races (89.4km) by 81% and these
changes seemed to correlate with fitness level of the athlete [197]. Additionally, three weeks
after the race, these same athletes experienced no change in LPS concentration following a
21.1km run, perhaps due to exercise-induced adaptation of increased IgG binding to circulating
LPS [197]. Changes in LPS concentration found acutely after exercise coincide with acute
changes in pro-inflammatory cytokines. Increases in circulating TNFα have been found
following 2.5h of running [198] and IL-6 immediately after a 10km [197] or 20km run [199].
Other studies using exogenous LPS stimulation of cultured macrophages from whole
blood or cultured peripheral whole blood access the effects of exercise conditioning on immune
response; whether exercise enhances or attenuates the immune response. LPS stimulation has
been shown to increase TNFα production in peripheral blood cultures following 30 minutes of
rowing when compared to controls that did not complete a rowing bout [200]. Chronic, moderate
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intensity endurance exercise training in mice also leads to increased sensitivity to LPS
stimulation, acutely, with increases in TNFα and IFNγ and concominant decreases in IL-10 (24h
after exercise and 24h after LPS stimulation) [196]. Conflicting data on the effects of exerciseinduced inflammatory modulations on LPS response in culture do exist. For example, male
cyclists showed attenuated TNFα increases in response to LPS stimulation after 3 hours of
cycling [36]. Differences in changes of TNFα seen with LPS stimulation may be due to the
intensity, duration, or modality of exercise used in the protocol. Also, sampling and assay
procedure may affect the outcome of the experiments and account for different results. Another
explanation for differences in results may be due to diet in the experimental groups. For
example, cyclists were allowed to consume water, tea, or coffee during their experimental trial.
Because both coffee and tea contain caffeine, and caffeine increases prostaglandin E (PDE), a
protein responsible for inhibiting the breakdown of the transcriptional factor cAMP, variation
due to differences in transcriptional regulation of cytokines and differences in catecholamine
secretion may account for the differences seen between the aforementioned studies.
Other macrophage plasma receptors also change in response to exercise, independent of
inflammatory stimuli. For examples, studies show that exercise changes presentation of several
CD receptors on the plasma membranes of circulating macrophages. Increases in CD64L have
been found 24h after exercise as well as decreases in CD4 expression at 6 h after exercise,
indicating a decrease in monocyte activation [201]. CD64L is a cell surface antigen that allows
monocytes to attach to endothelium. Thus, increases in CD64L may be induced during an
exercise bout in order infiltrate damaged muscle and help recruit leukocytes to the area to initiate
repair. CD4 is a cell surface antigen found on T helper cells and monocytes that is used to
“activate” monocytes and induce inflammation. Thus, downregulation of this receptor may lead
to changes in inflammatory cytokine production from circulating macrophages / monocytes after
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exercise. Additionally, CD64 expression, along with CD18 expression, is shown to decrease after
repeated bouts of exercise [29]. Transient increases in activated macrophages may be an
indication of enhanced immunity within exercise populations dependent on exercise intensity or
duration, corresponding to muscular damage initiated during the bout. Thus, concomitant
decreases in damage during chronic exercise may correlate with decreases in CD receptor
expression on activated macrophages.
Although CD receptors are good indices of changes in immunity, recent focus on indirect
adaptations that may confer alterations with physical activity explore the possibility of TLR2 and
TLR4 as the mediating key plasma receptors in the model of exercise-induced inflammation.
TLRs are a six member family of transmembrane receptors possessing an extracellular leucinerich repeat (LRR) domain and a cytoplasmic domain [202-204]. TLRs found on several cell
types, including macrophages, which may explain exercise-induced alterations in immune
response. TLRs function to recognize pathogens and link the innate immune response to the
adaptive immune response. Stimulation of the inflammatory response through TLR2 and TLR4
causes a signaling cascade that promotes inflammation through activation of NF-kB [205-207].
Activation of TLRs on macrophages ultimately leads to production of TNFα, IL-6, and IL-1β
[208]. Other adaptations to TLR activation on macrophages include presentation of CD80/86
and major histocompatibilty complex II (MHC II) on the macrophage plasma membrane, both of
which allow recognition of the macrophages by other recruited leukocytes in the area [209].
Furthermore, production of pro-inflammatory cytokines is directly correlated with TLR4
expression on macrophages [210]. TLRs may retain the ability to control inflammation in
response to exercise, whereby TLR activation on macrophages due to exercise leads to the
production and secretion of pro-inflammatory cytokines into the circulation. A viable
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explanation whereby repeated bouts of exercise decreases chronic inflammation may be due to
changes in cell surface expression of TLRs on systemic macrophages.
Several studies support this hypothesis of exercise-induced changes in the proinflammatory receptor, TLR, and inflammation. Prolonged aerobic exercise in the form of
cycling (two and half hours at 60% Vo2 max) has been shown to decrease cell surface expression
of TLRs on macrophages [209, 211]. Furthermore, decreases in TLR2 and TLR4 with exercise
training coincide with decreases in IL-6 production and MHC II and CD80/86 presentation
[211]. Other studies utilizing resistance training have confounding conclusions. In a cross
sectional study, resistance trained elderly women showed significantly decreased in TLR4
mRNA in conjunction with decreased production of IL-6, IL-1β, and TNFα after LPS stimulation
of whole blood cultures when compared to sedentary controls [212]. Yet, in a separate training
study, when blood is taken immediately post exercise, TLR4 is significantly increased compared
to the control group resting sample but is not different from the exercise trained resting sample
[212]. In the same study, however, resting blood levels of TLR4 decreased in exercise-trained
individuals compared to untrained control individuals. Furthermore, no changes were seen in
TLR4 following a twelve week resistance and endurance training intervention when compared to
baseline TLR4 values as well as resting control TLR4 values [22]. Conversely, TLR4 has been
shown to decrease in response to a combined endurance and resistance exercise training regimen
[38]. Limitations to the present body of data on exercise-induced changes in TLR expression
include the training regimen and blood sampling time, which may explain the differences seen in
TLR expression in response to training.
2.6.4 Influence of Exercise Mode, Intensity, and Duration on Macrophage Function
In all exercise based studies, it is important to note the differences and similarities in
exercise mode, intensity, and duration used as treatment. Mode, intensity, and duration all play a
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role in determining activation of differential metabolic systems during an exercise bout;
oxidative phosphorylation or glycolytic respiration [213-214]. Oxidative phosphorylation
involves the metabolism of glucose, either plasma glucose / glycogen derived glucose or beta
oxidation of free fatty acids (FFA), by type I oxidative muscle fibers or type IIa intermediate
muscle fibers. Utilization of either glucose of FFA is further dependent on the duration of the
exercise bout [213]. Glucose is first utilized during low intensity bouts, followed by oxidation of
FFA during longer duration low intensity exercise bouts. Both fuel sources require the presence
of oxygen within the mycocyte mitochondria as the final electron acceptor.
Several factors influence the rate at which aerobic versus anaerobic respiration take
place. Perhaps foremost oxygen delivery and utilization by myocyte mitochondria determines the
type of respiration [215]. Upon inspiration oxygen crosses from the aveoli within the lungs to
surrounding capillaries where it binds hemoglobin within the red blood cells (RBC) [216]
Oxygenated blood then flows from the lungs to the left atrium then the left ventricle and out to
the systemic circulation. During exercise, blood flow is redistributed from the splanchnic organs
to working muscles where formation of ATP is critical for continued muscle contraction [217].
Increased amounts of oxygenated blood are delivered to the myocyte. Once at the myocyte,
oxygen dissociates from hemoglobin, crosses the sarcolemma, and binds to high affinity
myoglobin within the muscle cells. Myoglobin works to deliver the oxygen from the outside of
the myocyte to the mitochondria [218]. At the mitochondria, oxygen can be used as the final
electron acceptor for hydrogen ions formed from oxidation of NADH and FADH in the electron
transport chain, ultimately forming water. The ability of aerobic respiration to take place is
dependent on fuel availability, mitochondrial content, mitochondrial enzyme function,
hemoglobin content, RBC count, myoglobin content, and fuel source. Conversely, anaerobic
respiration utilizes plasma glucose or glycogen derived glucose or phosphocreatine, without the
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presence of oxygen, as possible fuel sources for ATP formation and, thus, is not dependent on
mitochondrial number or function, hemoglobin, myoglobin, or RBC count. Instead, anaerobic
respiration is dependent on fuel availability and enzyme activity.
Additionally, oxidative versus glycolytic forms of respiration are dependent on
differential recruitment of muscle fiber type. There are two general phenotypes of recognized
muscle fibers; type I and type II fibers. Type I fibers are distinctive under a light microscope by
their dark coloration, due to high amounts of myoglobin within the fibers. Type I fibers possess
large amounts of mitochondria and are innervated by small diameter alpha motor neurons,
causing a slower transmission of electrical signals from the spinal cord needed to depolarize the
myocyte. Thus, type I fibers are considered slow twitch fiber types that utilize forms of oxidative
phosphorylation [219]. Muscle groups compromised of mostly red fibers are mostly type I fibers
and generate less power and velocity of shortening yet can sustain cycling contraction /
relaxation for long durations [32]. Type II fibers are lighter in color than type I fibers, indicating
less mygoblin content. These fibers also contain less mitochondria than type I fibers and are
innervated by larger diameter alpha motor neurons, allowing faster transmission of electrical
signals from the spinal cord [219]. Type II fibers can be further subcategorized based on the type
of myosin ATPase present in the fiber. Type IIa fibers are generally referred to as intermediate
fibers, as they have characteristics found in type I fibers. Type IIa fibers can use either aerobic or
anaerobic pathways for ATP formation. Type IIx fibers are generally referred to as fast
glycolytic fibers, as they are used during high intensity physical activity of short duration [219].
Muscle groups composed of white fibers are mostly type II fibers that can generate large power
output and a faster velocity of shortening but can only sustain cycling contraction / relaxation for
short periods of time. In addition some muscles are mixed muscles, meaning they contain both
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red and white fibers and can perform either low power long duration or high power short
duration exercises [32].
Due to differential recruitment of fiber phenotype with exercise modality, intensity, and
duration, there are differential by-products and end products. With both aerobic and anaerobic
exercise, by-products include hydrogen ions from the intermediate reactions of glycolysis, lactate
from pyruvate if there is little oxygen present, and conversion of lactate into lactic acid [220222]. Consequently, anaerobic respiration will cause formation of elevated levels of lactate and
lactic acid in the circulation in comparison to aerobic respiration. It is important to take these byproducts into consideration when evaluating the immune response to exercise, as several
researchers have noted that they contribute to decreases in blood and muscle pH, with larger
decreases seen in muscle pH. When pH is decreased below optimal levels, respiration will be
unable to continue due to dysfunctional enzymes, and exercise performance decreases [222]. It is
also plausible that formation of varying amounts of by-products may cause differences in the
circulating inflammatory profile and cytokine production. In fact, a positive direct correlation
exists between lactate levels and the anti-inflammatory cytokine, IL6, in young male wrestlers
[27].
Because various muscle groups are innately different from each other, it follows that
recruitment of differing fiber types as well as the amount of fibers or motor units recruited during
an exercise bout may play a role in differences seen in exercise-induced inflammation. Evidence
suggests that changes in systemic leukocyte number may be due to muscle recruitment, where
recruitment of larger muscle groups during an exercise bout leads to larger numbers of
circulating leukocytes afterwards and vice versa [29]. Researchers believe that the initial increase
in circulating pro-inflammatory cytokines is due to damage of the muscle during an exercise
bout. It seems plausible that contraction of large muscle groups and recruitment of more motor
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units during an exercise bout may potentially lead to increased damage and inflammation. A
positive correlation exists between leukocyte number after acute exercise and degree of soreness,
a possible measurement of muscle damage [201].
Another possible explanation for inflammatory differences associated with muscle size
may be due to the ability of larger muscle groups to increase core body temperature more
effectively than small muscle groups. Increases in body temperature increase activation of heat
shock proteins. Heat shock proteins in turn have been implicated in promoting a proinflammatory state, in conjunction with pro-inflammatory cytokines [13]. For example, heat
shock protein 70 (HSP70) has been shown to increase acutely after an intense endurance exercise
Ironman triathlon) bout involving whole body muscular contraction, especially large muscle
groups such as the quadriceps and hamstrings [24].
As previously stated, modality, intensity, and duration may all affect the peripheral
changes seen in circulating cytokines as well as leukocytes. Studies show high intensity exercise
(≥ 75% VO2max) leads to secretion of IL-6 more so than moderate or low intensity exercise
[14]. A positive correlation exists between leukocyte number after acute exercise and exercise
intensity and soreness [201, 223-224]. Researchers have found that short duration, low to
moderate intensity exercise is not without inflammatory benefits. Five or fifteen minutes of low
or moderate aerobic exercise in mice both lead to increases in the number of total leukocytes and
peritoneal macrophages as well as an increase in the phagocytic activity of the macrophages
[225]. Other increases in macrophage phagocytic activity have been noted after an acute bout of
endurance exercise (one hour of swimming) in rats and mice (thirty, sixty, and one hundred
twenty minutes of treadmill running) [35, 226]. In addition, peritoneal macrophage phagocytosis
has been shown to significantly increase in response to anaerobic exercise (plyometrics, 48h after
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exercise) in rats that have been immunocompromised by injection with tumor inducing cells
[227].
In addition to leukocyte recruitment and differential activation of macrophages as well as
increased phagocytic activity of macrophages associated with exercise, mode, intensity, duration,
and muscle group contraction also affect cytokine production. Studies show that several
modalities of exercise (cycling, running, eccentric, and knee extensor exercises) all significantly
increase levels of IL-6 acutely [181]. Other studies report that eccentric elbow flexion in young
(20-22 years), untrained male individuals leads to no changes in IL-6; although, the protocol for
the eccentric elbow flexion did not mention how much weight was lifted by participants and how
this related to the intensity of the eccentric bout. Furthermore, the exercise session only included
eccentric elbow flexion, 5 sets of 6 reps with 2 minutes of rest in between sets [17]. It appears
that perhaps intensity may play a larger role in exercise-induced inflammation than modality. For
instance, changes seen in IL-6 and IL-1 acutely after eccentric exercise directly vary with
intensity of the eccentric exercise, where changes are seen with moderate intensity eccentric
exercise but larger increases are seen with high intensity (≥ 75% VO2max) eccentric exercise
[29]. Changes in other pro-inflammatory cytokines also appear to be dependent on exercise
intensity. TNFα has been shown to significantly increase acutely after a moderate shuttle walk
test, and this increase was magnified using a higher intensity strenuous shuttle walk test in the
same group [228]. After one month of daily training in these same participants, TNFα decreased
after an acute shuttle walk test. Exercise intensity plays a large role in determining inflammatory
response to exercise, and exercise training leads to adaptations in response to repeated acute
upregulation of pro-inflammatory cytokines that may desensitize leukocytes to these cytokines.
Conversely, there may be no desensitization, but rather sensitization of leukocytes to proinflammatory cytokines with chronic exercise, leading to a sensitization of anti-inflammatory
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pathways and a faster or more efficient response of the anti-inflammatory pathways to stimulus,
eventually causing the decreases in TNFα and other pro-inflammatory cytokines seen acutely
after an exercise bout in trained individuals.
Other evidence exists to support the role of exercise intensity and duration in regulating
the immune response. After an intense Ironman triathlon, IL-6 and IL-10 were elevated acutely
(thirty minutes post exercise) and returned to baseline levels within one day [24]. Marathon
racers also experience increases in IL-6, IL-10, TNFα, and Il-1β acutely after a race [29].
Furthermore, IL-6, TNFα, and IL-1β are acutely elevated when a combination of intense aerobic
and anaerobic wrestling bout is performed in young male wrestlers [27].
2.6.5 Age May Influence Inflammatory Responses to Exercise
In addition to intensity, duration, and modality, evidence is suggestive of a role of muscle
fiber type and size in inducing inflammation acutely after an exercise bout. It follows that age of
participants may also affect the inflammatory response to exercise. With age, atrophy of muscle
occurs, decreasing strength and mass of the muscle. Additionally, changes in fiber type occur
with aging. Over time the predominant muscle fiber type becomes type I, slow twitch oxidative
fibers in elderly individuals. The change in muscle fiber type and increases in atrophy lead to
reduced velocity of shortening of the muscle during contraction and decreases in force
development and, consequently, power output [29]. Studies show that changes in leukocytosis
also occur with aging. Elderly males have exhibited attenuated response of neutrophils in the
systemic circulation, with 20% less recruitment when compared to young males [29]. Changes in
systemic cytokines in response to exercise have also been reported to be dependent on age. IL-6
production and secretion after downhill running in elderly males is only equal to 90% of the IL-6
produced and secreted during the same exercise bout in young males [29]. In addition, IL-6,
TNFα, IL-1β, and IL-10 exhibit attenuated elevation in response to LPS stimulation of
47

macrophages in aged mice when compared to younger mice [229-230]. Although changes in
circulating cytokine production have been seen in response to exercise and LPS stimulation in
humans and mice, respectively, the mechanism for these changes in unclear and little research
has explored the mechanism behind the differences associated with aging. It does appear,
however, that the changes seen with age may not involve changes in receptor expression on
macrophages. Studies show no significant changes in TLR expression in young versus older
humans, although aged mice do exhibit decreased amounts of TLR4 when compared to younger
mice [18, 230-232].
2.7 Literature Review Summary
Extensive research has been conducted on changes in pro- and anti-inflammatory
cytokines in response to exercise bouts and training. Several representative studies have been
reported here in order to demonstrate the changes seen acutely and chronically after exercise. All
agree that exercise induces secretion of acute phase reactants into the systemic circulation,
promoting inflammation, and that chronic phase reactants are found in the systemic circulation in
response to long term exercise training. Where these studies differ is in the explanation of where
and how these circulating cytokines are secreted. While several studies propose that proinflammatory cytokines are secreted from circulating leukocytes acutely after exercise, others
express the conclusion that pro-inflammatory cytokines are produced from myocytes in response
to muscle damage caused by the bout itself. Whether pro-inflammatory cytokines are secreted by
circulating leukocytes or myocytes remains an area of debate, while a consensus exists amongst
researchers regard to the source of production and secretion of anti-inflammatory cytokines in
response to chronic exercise. Researchers agree that the presence of pro-inflammatory cytokines
seen acutely after exercise lead to concomitant increases in anti-inflammatory cytokines from
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circulating leukocytes. These adaptations to chronic exercise help to explain the beneficial
effects of exercise training in diseased populations that exhibit low grade chronic inflammation.
While it is agreed that exercise training leads to beneficial adaptations within the
inflammatory response, the mechanism behind these exercise-induced changes in systemic
cytokine profile remains unclear. It is most likely, given the redundancy of the biological system,
that several adaptations to exercise training culminate to create a reduction in chronic
inflammation. Changes in immune cell response are affected by several different mechanisms. It
is possible for one researcher to illuminate these changes due to the magnitude of the task. First,
there are several subpopulations of leukocytes to take into account in affecting inflammation.
Second, subpopulations are derived from different tissues in response to different signals. Third,
different types of stimuli on the immune system cause differential expression of populations of
immune cells. Furthermore, within subpopulations, there is differential phenotype expression of
immune cells. Fourth, populations exhibit various expression patterns of recognition receptors in
response to varying stimuli. Activation of different receptors leads to differing downstream gene
and protein expression patterns. Additionally, various receptors, either on the same cell or other
immune cells, may communicate through cross-talk, complicating pathway activation or
repression in order to regulation gene and protein expression. Although a consensus is seen in the
end product of exercise training on inflammation, elucidating the mechanisms behind these
changes remains a daunting task.
I have concentrated this review and my studies on the immune response of monocytes
and macrophages to exercise, acutely and chronically. Several mechanisms for changes in
inflammatory cytokine secretion from macrophages have been proposed and studied. Most
notably, differential expression of the β-ARs and TLRs have been researched as effectors of
exercise-induced changes in inflammation. Each class of receptor seems to play a crucial and
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opposite role in mediating cytokine production in macrophages. TLR2 and TLR4 induce
inflammation by causing upregulation of pro-inflammatory cytokine production; whereas, β-ARs
are noted to cause upregulation of anti-inflammatory cytokines. β-ARs and TLRs respond to
different stimuli. β-ARs respond to catecholamines, Epi and NE, while TLRs respond to LPS and
other endotoxin pathogens. It appears that induction of the pro-inflammatory response is due to
damage of myocytes during an exercise bout, and induction of the anti-inflammatory response is
due to changes in endocrine hormone circulation during and after an exercise bout. Although,
the β-ARs and TLRs appear to regulate exercise-induced changes in inflammation, studies of
changes in receptor expression in response to exercise remain controversial.
Few other macrophage plasma receptors have been extensively studied in response to
exercise. It is known that macrophages, integral in the response to stress and initiators of the
immune response, possess MCRs. MC3Rs are important in regulation of metabolic responses,
such as nutrient partitioning, in the hypothalamus within the CNS, where they are activated by
various derivatives of the propeptide POMC, including ACTH, α-MSH, β-MSH, and γ-MSH.
In addition to the potential role of the MC3R in the CNS in regulating nutrient
partitioning, recent investigations have concentrated on MC3R expression in peripheral tissues.
One additional role of MC3R may be its ability to regulate circadian rhythms through integration
with the food entrainable oscillator. Another function of MC3R in the periphery focuses on its
expression on macrophages. Studies have shown that activation of the POMC neurons occurs
during inflammation in response to pro-inflammatory cytokines; IL-6, IL-1β, and TNFα. This
translates to increased ACTH secretion in the hypothalamus. Studies also show that circulating
POMC and ACTH levels are increased during inflammation in the periphery. MC3Rs have been
shown to play a role in cytokine production from macrophages in response to stress. Activation
of the MC1R and MC3R causes macrophages to secrete IL-10, an anti-inflammatory cytokine,
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which in turn inhibits secretion of IL-6, IL-1β, and TNFα from leukocytes. It appears that the
MC3R may function in a comparable manner within the periphery as within the CNS, where the
melanocortin system is expressed in both locations, but different outcomes are present in
response to MC3R activation. In peripheral tissues, MC3R may function to regulate
inflammation through its expression on systemic macrophages. The immunomodulatory role of
the MC3R on monocytes may further be amplified by activation of the MC1R. Furthermore,
MC1R and MC3R expression may be affected by exercise and activation seems a plausible
regulatory adaptation of the anti-inflammatory response to chronic exercise.
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CHAPTER 3. RESISTANCE EXERCISE ALTERS MONOCYTE MELANOCORTIN
RECEPTOR EXPRESSION
3.1 Introduction
Exercise training has been shown to create favorable changes in inflammatory profiles.
Specifically, resistance training has been shown to dowregulate systemic pro-inflammatory
cytokines associated with chronic inflammation and upregulate anti-inflammatory cytokines [39,
174-175]. It has been established that exercise training results in chronic downregulation of
inflammatory cytokine production and secretion within circulating monocyte populations via
downregulation of the toll-like receptors [205-208]. Whereas regulatory pro-inflammatory
receptors have been identified on monocytes, few studies have examined possible antiinflammatory receptors that may regulate changes in anti-inflammatory pathways associated with
chronic exercise training. The MC3R is a member of five GPCRs that make up the melanocortin
receptor family, MC1R through MC5R. MC3R is known to increase secretion of the antiinflammatory cytokine, IL-10, from cultured macrophages [71, 74]. Additionally, activation of
MC3R with agonist leads to downregulation of the pro-inflammatory cytokines, IL-6 and TNFα,
from cultured macrophages in response to inflammatory stimuli, likely due to upregulation of IL10 [74-75]. In addition to MC3R, monocytes as well as several other immune cell populations
have been shown to express MC1R and MC5R [67, 82]. Whereas MC5R has not been shown to
be critical in regulating cytokine expression and secretion from monocytes and macrophages,
MC1R and MC3R have both been shown to have redundant modulatory roles within monocyte
and macrophages cell lines [69-70].
Although multiple lines of evidence suggest that MC3R plays an immunomodulatory role
through regulation of gene expression in macrophage cell lines, to our knowledge, no studies
have explored the effects of exercise training on monocyte MC3R expression. I recently found
that MC3R mRNA expression increased 13-fold in whole blood samples taken after a 12 week
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resistance training intervention. Thus, my current efforts have been focused on determining
whether changes in MC3R mRNA translate to changes in MC3R protein expression on the
plasma membrane of systemic monocytes.
In the present study, I examined the modulation of MC1R and MC3R expression in
response to resistance training in young, healthy adults. My results clearly demonstrate that
resistance training increases the number of monocytes expressing MC1R but decreases the
number expressing MC3R. In addition, I show that MC1R and MC3R receptor density on
monocytes decreases in response to resistance training. I also show that changes in MC3R but
not MC1R expression negatively correlates to changes in body composition. Resistance training
also leads to changes in the inflammatory profile, evidenced by decreases in CRP and transient
upregulation of IL-6 and chronic decreases in IL-10 protein expression.
3.2 Materials and Methods
3.2.1 Participants and Screening
Thirty-nine healthy, physically active college-aged students were recruited for this study.
The resistance training group (n = 23) consisted of interested males and females from a senior
level Kinesiology course (KIN 4501-The Physiology of Strength Training) at Louisiana State
University. Students learned advanced techniques in strength training and completed the below
measurements as part of the class. Students interested in the training group portion of this study
were asked if they were interested in allowing us to use data collected in the class for research
purposes. Students were not penalized for not participating in the study. An “active control”
group (n = 19) consisted of active males and females who participated in an endurance or
resistance training program on a regular basis. The active control group participants were
recruited by word of mouth. This project was approved by the LSU Intuitional Review Board.
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3.2.2 Preliminary Testing
Medical Screening, Health History and Physical Activity Questionnaires
Subjects in the training group received permission to participate from a State licensed
M.D. All study participants (training and active control) completed a medical history form.
Additionally, all participants filled out the International Physical Activity Questionnaire (IPAQ)Short Format [233]. The IPAQ-short format is an instrument that can be used to obtain
internationally comparable estimates of physical activity with adults aged 18-65 yr. It is designed
to assess health-related aspects of physical activity and sedentary behaviors. The short version
contains 4 items (7 questions) targeting time spent in vigorous- and moderate-intensity activity,
walking, and in sedentary activity. The screening and questionnaires were designed specifically
with the participant’s health in mind by: 1) preventing those with pre-existing conditions from
participating in a running program/study and 2) allowing the researchers to become aware of any
potential health issues.
3.2.3 Baseline Resting Measurements
Baseline measurements in both training and control groups were taken in the Exercise
Physiology Laboratory at Louisiana State University (LSU). Subjects were instructed to refrain
from exercising on the day of testing. Upon arrival, the subjects were given the Informed
Consent form and given time to review the document. Then, the investigator explained the
experimental protocol and answered any questions.
Body Composition
Body density was assessed using Dual X-ray Absorptiometry (DXA) in the Nutrition and
Health Assement Laboratory in the School of Human Ecology at LSU. Subject age, gender,
ethnicity, and height and weight were entered into the DXA apparatus (Prodigy Pro, GE Lunar
Medical Systems, Madison, WI). Participants were then asked to remove all of their jewelry and
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metal objects and lie on their back on the DXA table. T
They
hey remained on their back for the
duration of the scan, about 5 minutes or less. All measurements were taken by a trained DXA
operator (Tara M. Henagan).
Resting Metabolic Rate (RMR)
Subjects underwent a test for resting metabolic rate (RMR) at the begin
beginning of the
training intervention (or normal activity in active control) (PRE) and end (POST) of the 12
12-week
experimental period. RMR was obtained while subjects rested quietly for 30 minutes and
breathed into a mouthpiece so that expired air was collecte
collectedd and analyzed for oxygen
consumption, carbon dioxide production and total ventilation as previously described [234].
Blood Sampling
Participants were asked to report to the lab aft
after
er an overnight fast and refraining from
exercise from the previous 72 hours between 0800
0800-1100
1100 h and rest quietly for at least 15 minutes
before the baseline, pre-training
ing blood sample were obtained PRE. Approximately 8 mL of
blood was obtained by a registered
stered nurse from an antecubital vein. Aliquots were treated with
EDTA (BD-Pharmingen,
Pharmingen, USA). At the end of the twelve week training per
period, blood was
collected again POST from both the active control and trained group 72 hours after their last
resistance training bout.

FIGURE 1. Study Timeline
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3.2.4 Acclimation and Training
Acclimation
Both the active control and training groups completed a 2 week-long acclimation period
to the following resistance exercises: bench press, bent over rows, shoulder press, barbell curls,
dumbell shrugs, tricep pressdowns, crunches, squat, deadlift, walking lunges, lying leg curl, leg
extension, and standing and seated calve raises. They performed four acclimation exercise
sessions on non-consecutive days (Monday and Wednesday or Wednesday and Friday). On
acclimation day 1 (ACC 1), participants were taught proper lifting techniques for each of the
seven upper body exercies to minimize the risk of injury. Each subject in the control and trained
groups performed one set of 10-15 repetitions of bench press, bent over rows, barbell curls,
dumbell shrugs, tricep pressdowns, and crunches. On the second acclimation day (ACC2),
participants were taught proper lifting techniques for each of the seven lower body exercies to
minimize the risk of injury. Participants then performed one set of 10-15 repetitions of each
exercise; squat, deadlift, walking lunges, lying leg curl, leg extension, and standing and seated
calve raises. On the third acclimation day (ACC3), participants performed the same exercises as
ACC1 but performed two sets of each at 10-15 repetitions. One the fourth acclimation day
(ACC4), participants performed the same exercises as ACC2 but performed two sets of each at
10-15 repetitions. 8-RM for bench press, squat, and deadlift exercises was assessed on ACC3
and ACC4. All acclimation and exercise sessions were preceded by 5-10 min of cycle ergometry
or walking. All acclimation sessions and resistance exercise sessions were completed in the
Stadium Weight Room or University Recreational Center at LSU under the supervision of
trained technicians. (See Figure 1.)
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8 RM testing
Following the acclimation period but before the intervention period and following the
intervention period, CON and RT individuals underwent 8RM testing for bench press and squat.
Subjects were asked to perform one set of 10 – 12 repetitions of lift weight as a warm up set.
Subjects then rested for 2-3 mins. Based on the individuals assessment, a suitable weight was
determined in the use of the 8RM testing. The subject was asked to perform 8 repetitions,
coming to complete muscle failure by the eighth repetition. If the subject could not complete 8
repetitions or completed more than 8 repetitions at the current weight, the weight was increased
or decreased by 5-10% accordingly. The subject was then asked to perform the lift again with the
goal being complete muscle failure by the eighth repetition. The subject rested 2-3 mins between
tries if the 8RM was not reached on the first try. The subject was allowed 3 tries to reach the
8RM for a specific lift. Upon competion of the 8RM, the weight was recorded for each subject. If
the subject did not reach the 8RM by the third try, the weight lifted and the number of repetitions
was recorded. The 8RM was then determined using the CSCS calculation for RM testing.
Training
Following the acclimation and testing period, the training group completed 12 weeks of
progressive resistance training on non-consecutive days (3x / week) and were asked to maintain
their normal diet. Subjects in the training group were provided with a training routine to follow.
The training was periodized and progressive (Appendix 1). Progression was implemented by
asking participants to complete a given repetition range for a specified number of sets for each
lift until failure. If the participant was able to complete and repetitions for all sets of a given lift
without reaching failure, the load was increased during the following training period until failure
was reached. Participants were supervised to ensure proper lifting techniques for each of the
exercise to minimize the risk of injury and proper progression through the training plan. The
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active control group did not undergo supervised exercise sessions, but were asked to maintain
their normal activity and eating habits.
3.2.5 Post Intervention Data Collection
Post intervention measures were performed on all participants following the 12 week
intervention. Procedures for post-training measurements were identical to the protocol followed
for the baseline resting and exercise measures outlined above.
3.2.6 Blood Analyses
Flow Cytometry
EDTA-treated blood was incubated with either MC1R (Santa Cruz) or MC3R (Amolone)
or CD14 (eBioscience) antibody as well as a three-color isotope control. The percent variation in
MC3R over a 3 day time period was 7.35% (P = 0.89) for the percentage of monocytes
expressing MC3R and 0.50% (P = 0.94) for MC3R MFI. Primary gates were established on
leukocyte populations using forward and side scatter light; secondary gating was established
using CD14 to identify and analyze monocyte populations. All experiments were performed
using the FACS Laboratory at the LSU School of Veterinary Medicine.
Serum Cytokine Profiles
Plasma was collected from EDTA-treated whole blood samples by centrifugation (14000
rpm, 4°C, 10 minutes) immediately following blood collection and was used in commercially
available ELISA kits to measure amounts of CRP (ALPCO) and circulating cytokines IL-6
(eBioscience) and IL-10 (eBioscience). Intra-assay coefficients of variation were 6%, 4.9%, and
6.8% Inter-assay coefficients were 13.8%, 6.0%, and 7.5% for CRP, IL-6 and IL-10 respectively.
3.2.7 Statistical Procedures
The two-tailed Student t-test, linear regression, and a 2 (PRE vs. POST) X 2 (CON vs.
RT) repeated measures analysis of variance (ANOVA) were used for determining the
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significance of the experimental differences when appropriate. Significance was set at P < 0.05.
Bonferroni post hoc tests were used when appropriate. All statistical analyses were performed
using GraphPad Prism or JMP statistical software. Correlations were determined using linear
regression analysis in GraphPad Prism software. All values reported are means ± SEM.
3.3 Results
Nineteen subjects were enrolled in the CON group and twenty-three subjects were in the
RT group, two CON subjects dropped out over the course of the 12 week intervention period and
all RT participants completed the study. Even though this study was not designed to determine a
gender effect, relatively equal numbers of men and women were used in this study. The CON
and EX group consisted of 7, 12 and 11, 12 male and female participants, respectively.
Age, height, and body weight (BW) variables were not different at baseline in CON and
RT and remained unchanged and not significantly different POST. Age ranged from 20 to 27 yr
in the CON group and from 18 to 27 yr in the RT group. Height ranged from 152.2 to 190.5 cm
in the CON group and from 156.2 to 184.7 cm in the RT group (TABLE 1). BW ranged from
47.17 to 136.08 kg in the CON group and from 53.43 to 158.3 kg in the RT group before the
intervention and did not change in both groups after the intervention period (TABLE 1). BMI
ranged from 19.85 to 37.5 kg/m2 in CON and from 19.78 to 45.42 kg/m2 in RT prior to the
intervention period and did not change significantly in either CON or RT after the intervention
period (TABLE 1).
There were no differences in lean body mass (LBM) percentage or LBM or body fat
percentage between CON and RT groups at baseline (FIGURES 2 and 3 and 6), however
participants in the RT group significantly increased LBM by 1.15 ± 0.27 kg (POST – PRE), a
1.84 ± 0.46% increase (FIGURES 4 and 5). This increase was significantly larger than the
change in LBM seen in CON (0.29 ± 0.28 kg, POST – PRE), a 0.63 ± 0.34% change (FIGURES
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4 and 5). Furthermore, the change in body fat percentage was significantly different in RT, who
had a 1.55 ± 0.45% decrease in body fat percentage (POST – PRE), and CON, who had a 0.54 ±
0.35% decrease in body fat percentage (POST – PRE, FIGURE 7). There were no significant
changes in bone mineral content (BMC) PRE or POST in CON (2.74 ± 0.17 kg PRE vs. 2.48 ±
0.17 kg POST) and RT (2.98 ± 0.13 kg PRE vs. 2.97 ± 0.12 kg POST). There were no significant
differences in RMR or RER in either CON or RT (TABLE 2).
TABLE 1. Descriptive data for subjects.
Descriptive data for the subjects before (Pre) and after (Post) the 12-week resistance training
intervention. CON, active control group; RT, resistance training group.
* denotes significant differences between CON and RT groups.

Variable

CON

RT

(n=18)

(n=22)

21.4 ± 0.42

22.2 ± 0.38

166.32 ± 2.14

171.85 ± 1.94

Pre

68.12 ± 4.98

75.49 ± 4.61

Post

67.76 ± 4.88

74.84 ± 4.41

Pre

24.18 ± 1.19

24.23 ± 1.04

Post

24.07 ± 1.10

24.06 ± 0.99

Bench Press

-11.44 ± 4.04
(n=7)

5.58 ± 3.01*
(n=15)

Squat

-5.18 ± 4.28
(n=6)

11.82 ± 3.02*
(n=14)

Time

Age

Height (cm)

Body Weight (kg)

BMI (kg/m2)

8RM Test (% change)
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3.3.1 Training Program Results
Compliance was recorded weekly through self recorded workout logs All exercise
participants completed 92% of the prescribed exercise sessions. The RT group experienced
significant increases in 8RM in both bench press and squat and the percent change in strength
was significantly greater in RT compared to CON after the intervention period. The RT
experienced 5.58% ± 3.01 (143.05 ± 17.92 PRE vs. 156.75 ± 18.58 POST) and 11.82% ± 3.02
(170.83 ± 15.93 PRE vs. 193.11 ± 19.29 POST) increases in the bench press and squat
respectively (TABLE 1). The amount of work performed each week by the RT group varied, as
an undulating periodized routine was utilized over the twelve week period. The lowest work
completed was during weeks 3 and 9 and the highest at weeks 7 and 8. The number of repetitions
recommended ranged throughout the 12 week intervention from 442 repetitions per week to
1275 repetitions per week (Appendix A).
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FIGURE 2. LBM percentage.
Lean body mass (LBM) percentage before (PRE) and after (POST) the intervention period.
CON, active control group; RT, resistance training group. There were no significant differences
in LBM percentage in RT or CON PRE to POST.
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FIGURE 3. LBM.
Lean body mass (LBM) before (PRE) and after (POST) the intervention period. CON, active
control group; RT, resistance training group. There was a significant interaction between time
and treatment effect on LBM (P < 0.05 by two way ANOVA).

Change in Lean Body Mass
Percentage (post % - pre %)

2.5

*

2.0
1.5
1.0
0.5
0.0
CON

RT

Treatment

FIGURE 4. Change in LBM percentage (POST – PRE).
CON, active control group; RT, resistance training group. The change in lean body mass (LBM)
percentage (POST – PRE) was significantly larger in the RT vs. the CON group (P < 0.05 by t
test). *denotes significant difference between CON and RT groups
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Change in LBM
(POST (kg) - PRE (kg))
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FIGURE 5. Change in LBM (POST – PRE).
CON, active control group; RT, resistance training group. The change in lean body mass (LBM;
POST – P5E) was significantly larger in the RT vs. the CON group (P < 0.05 by t test). *denotes
significant difference between CON and RT groups

CON
RT

Body Fat Percentage

30
25
20
15
10
5
0
PRE

POST

PRE

POST

Time

FIGURE 6. Body fat percentage.
Body fat percentage before (PRE) and after (POST) the intervention period. CON, active control
group; RT, resistance training group. There were no significant differences in body fat
percentage in RT or CON.
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FIGURE 7. Change in body fat percentage (POST – PRE).
Change in body fat percentage (POST – PRE). CON, active control group; RT, resistance
training group. Decreases in body fat percentage were significantly large in RT than CON. (P <
0.05 by Students t test). *denotes significant difference between CON and RT groups.
TABLE 2. RMR and RER.
Resting metabolic rate (RMR) and respiratory exchange ratio (RER) before (Pre) and after (Post)
the intervention period. Values are means ± SEM. CON, active control group; RT, resistance
training group

Variable

RMR (kcal / day)

RER

Time

CON (n=19)

RT (n=22)

Pre

1915.64 ± 117.91

2045.36 ± 106.88

Post

1839.15 ± 76.94

2106.19 ± 110.29

Pre

0.80 ± 0.02

0.81 ± 0.01

Post

0.79 ± 0.01

0.83 ± 0.01
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3.3.2 Monocyte Cell Surface Expression of MC1R and MC3R
Prior to the intervention, there were no significant differences between CON and RT in
the percentage of monocytes expressing MC1R (82.16 ± 1.89% in CON vs. 84.11 ± 1.16% in
RT) or MC3R (7.75 ± 1.52% in CON vs. 12.33 ± 2.25% in RT; FIGURES 8 and 9). The
percentage of systemic monocytes expressing MC1R significantly increased from 84.11 ± 1.16%
to 91.41 ± 0.79 % in response to RT whereas the percentage of monocytes expressing MC1R in
the CON group did not change (82.16 ± 1.89% PRE vs. 83.36 ± 1.93% POST; FIGURE 8). The
percentage of monocytes expressing MC3R significantly decreased in RT (12.33 ± 2.25% PRE
vs. 6.47 ± 0.84% POST) with no change in CON (7.75 ± 1.52% PRE vs. 6.58 ± 1.3% POST),
although there was a significant effect of time (FIGURE 9). No differences in the amount of
MC1R and MC3R receptor density, determined by the mean fluorescence intensity (MFI), were
detected in baseline samples.

% Monocytes expressing
MC1R protein

100

CON
RT

*

75
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25

0
PRE

POST

PRE

POST

Time

FIGURE 8. Percentage (%) of systemic monocytes expressing melanocortin 1 receptor
(MC1R) protein on the cell surface.
Pre, before intervention; Post, after intervention. CON, active control group; RT, resistance
training group. The percentage of monocytes expressing MC1R protein increased in RT but not
CON after the intervention period (P < 0.001 by two way ANOVA). *denotes significant
difference between Pre and Post values within CON or RT groups
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FIGURE 9. Percentage (%) of systemic monocytes expressing melanocortin 3 receptor
(MC3R) on the cell surface.
Pre, before the intervention period; Post, after the intervention period. CON, active control
group; RT, resistance training group. The percentage of monocytes expressing MC3R protein
decreased in response to RT, and there was a significant effect of time in the model (P < 0.05 by
two way ANOVA). *denotes significant effect of time; Ψ denotes significant effect of treatment

At the POST time point, the amount of MC1R expressed on individual monocytes or the
MC1R MFI significantly decreased from 33.82 ± 2.31 PRE to 15.05 ± 0.92 POST in RT with no
change in MC1R MFI in CON (32.75 ± 2.33 PRE vs. 27.85 ± 2.94 POST; FIGURE 10). MC3R
MFI also significantly decreased in RT (20.3 ± 2.66 PRE vs. 11.85 ± 1.37 POST) and there was
a significant effect of time on MC3R MFI (FIGURE 11). MC1R MFI was not significantly
altered in CON 16.11 ± 1.62 PRE vs. 10.68 ± 1.35 POST; FIGURE 10).
Changes in the percentage of monocytes expressing MC1R did not significantly correlate
with MC1R MFI, body fat percentage, body fat (g), or RMR (kcal / d) (FIGURE 12, TABLE 3).
Changes in the percentage of monocytes expressing MC3R (POST – PRE) significantly
correlated with changes in MC3R MFI, body fat percentage, body fat (g), and RMR (kcal / d).
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FIGURE 10. Plasma membrane expression of melancortin 1 receptor (MC1R) per
monocyte.
CON, active control group; RT, resistance training group. Mean fluorescent intensity (MFI) of
MC1R expression in the RT group after the intervention (P < 0.001 by two way ANOVA).
*denotes significant difference in Pre and Post values within CON or RT groups.
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FIGURE 11. Melanocortin 3 receptor (MC3R) density on systemic monocytes.
Pre, before the intervention period; Post, after the intervention period. CON, active control
group; RT, resistance training group. The mean fluorescent density (MFI) of MC3R decreased in
RT after the intervention and there was a significant effect of time in the model (P < 0.01 for
treatment by two way ANOVA). *denotes significant effect of time; Ψ denotes significant effect
of treatment
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FIGURE 12. Correlations between the change in the percentage of monocytes expressing
MC1R and (A) the change in MC1R receptor density, (B) change in body fat percentage,
(C) change in body fat, and (D) change in energy expenditure.
CON, active control group; RT, resistance trained group.
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TABLE 3. Summary of correlations between changes in the percentage of monocytes
expressing MCRs and changes in MC3R or MC1R plasma receptor density, changes in
body fat percentage, changes in body fat, or changes in energy expenditure.
CON, active control group; RT, resistance training group. MFI, mean fluorescence intensity. EE,
energy expenditure. Values are reported as the correlation coefficient (top) and P value (bottom).
* indicates significance.

Treatment
Correlation Variables
Group
Correlation
Variables
Change in
percent
monocytes
expressing
MC3R
protein
CON
RT
Change in
percent
monocytes
expressing
MC1R
protein

CON
RT

Change
in MC3R
MFI

Change in
MC1R
MFI

0.6528,
0.0002*
0.7121,
< 0.001*

0.734,
< 0.0001*
0.1039,
0.1657

Change in
% Body
Fat

Change in
Body Fat

Change in
RMR (kcal /
day)

0.01213,
0.6847
0.295,
0.0198*

0.06851,
0.3274
0.2946,
0.0199*

0.06629,
0.3742
0.2553,
0.0273*

0.07297,
0.3958
0.005873,
0.77

0.005561,
0.8178
0.00747,
0.7487

0.00074,
0.9787
0.0313,
0.4688

The largest decreases in the percentage of monocytes expressing MC3R significantly
correlated with the smallest decreases in MC3R MFI (r2 = 0.7121; P < 0.0001) (FIGURE 13A).
The largest decreases in percent body fat (r2 = 0.295; P < 0.05) and fat (r2 = 0.295; P < 0.05)
significantly correlated with the smallest decreases in the percentage of monocytes expressing
MC3R (FIGURES 13B and 13C). Changes in RMR (kcal / day) significantly correlated with
changes in the percentage of monocytes expressing MC3R protein (r2 = 0.2553, P < 0.05;
FIGURE 13D; TABLE 3).
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FIGURE 13. Correlations between the change in the percentage of monocytes expressing
melanocortin 3 receptor (MC3R) and (A) the change in MC3R receptor density, (B) change
in body fat percentage, (C) change in body fat, and (D) change in energy expenditure.
CON, active control group; RT, resistance trained group
3.3.3 Plasma CRP and Cytokine Concentrations
There were no differences in CRP between CON and EX groups at baseline. CRP
plasma levels did not change significantly in RT or CON individuals (FIGURE 14). However,
CRP levels in RT decreased from a moderate risk for CVD category at the beginning of the study
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(1.71 ± 0.59) to a low risk category Post (0.9 ± 0.26 mg/mL). Additionally, when CRP levels
were placed in tertiles, the highest baseline tertile in the RT group experienced a significant
decrease in CRP at the end of the 12 week intervention (2.08 ± 0.34 PRE to 1.09 ± 0.34 POST),
with no changes seen in CON in any tertile (TABLE 4).

2.5

CON
EX

CRP (m g / L)

2.0
1.5
1.0
0.5
0.0

Pre

Post

Pre

Post

Time
FIGURE 14. C-Reactive Protein (CRP) plasma protein levels.
Pre, before the intervention period; Post, after the intervention period. CON, active control
group; RT, resistance training group. There were no significant differences in CRP in either
CON or RT groups Pre to Post.
There were no differences in IL-6 or IL-10 between CON and RT groups at baseline.
After the intervention there were no changes in IL-6 protein in RT or CON (FIGURE 15,
TABLE 4). IL-10 protein plasma levels significantly decreased in RT, but almost the same
degree of decrease was seen in CON individuals after the 12 week intervention (FIGURE 16,
TABLE 4). There was also a significant effect of time on IL-10 in both CON and RT (FIGURE
16, TABLE 4).
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FIGURE 15. Plasma interleukin-6 (IL-6) protein levels.
Pre, before the intervention period; Post, after the intervention period. CON, active control
group; RT, resistance training group. There were no significant differences in IL-6 in either CON
or RT groups.

IL-10 (pg / mL)

1.6
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RT

1.2

*

*

,ψ

0.8

0.4

0.0

Pre

Post

Pre
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Time

FIGURE 16. Interleukin-10 (IL-10) plasma protein levels.
Pre, before the intervention period; Post, after the intervention period. CON, active control
group; RT, resistance training group. IL-10 decreased in RT Pre vs. Post values. There was a
significant effect of time (P < 0.0001 by two way ANOVA). *denotes significant effect of time
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TABLE 4. Summary of plasma protein levels of C-reactive protein (CRP), interleukin 6
(IL-6), and interleukin 10 (IL-10).
Pre, before the intervention period; Post, after the intervention period. CON, active control
group; RT, resistance training group *denotes significant difference between Pre and Post values
within CON or RT groups
Variable

Time

CON

RT

CRP (total)

Pre

1.42 ± 0.38 (n = 14)

1.71 ± 0.59 (n = 16)

Post

1.46 ± 0.41

0.9 ± 0.26

Pre

3.32 ± 0.38 (n = 6)

2.08 ± 0.34 (n =9 )

Post

2.56 ± 0.60

1.09 ± 0.34*

Pre

1.04 ± 0.05 (n = 5)

0.41 ± 0.03 (n = 5)

Post

0.98 ± 0.34

0.35 ± 0.08

Pre

0.38 ± 0.08 (n = 5)

0.24 ± 0.02 (n = 5)

Post

1.23 ± 0.67

0.39 ± 0.09

Pre

0.88 ± 0.23 (n = 19)

0.72 ± 0.10 (n = 21)

Post

0.97 ± 0.14

0.98 ± 0.09

Pre

1.32 ± 0.17 (n = 19)

1.42 ± 0.17 (n = 21)

Post

0.78 ± 0.10*

0.87 ± 0.13*

CRP (highest tertile)

CRP (middle Tertile)

CRP (lowest tertile)

IL-6

IL-10

Changes in CRP correlated with changes in body composition. Larger decreases in body
fat percentage and body fat and larger gains in LBM directly correlated with larger decreases in
CRP (FIGURE 17, TABLE 5). Additionally, changes in IL-6 but not IL-10 also correlated with
changes in body composition. Larger increases in IL-6 correlated with larger decreases in body
fat percentage and body fat and larger increases in LBM percentage (FIGURE 17, TABLE 5).
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FIGURE 17. Correlation graphs between changes in CRP plasma protein levels and
changes in body composition.
Correlation graphs between changes in CRP plasma protein levels (Post – Pre) and (a) changes in
body fat percentage (Post – Pre), (b) changes in body fat (Post – Pre), and (c) changes in lean
body mass (LBM) percentage (Post – Pre). Also shown are correlations between changes in IL-6
plasma levels (Post – Pre) and (d) changes in body fat percentage (Post – Pre), (e) changes in
body fat (Post – Pre), and (f) changes in lean body mass (LBM) percentage (Post – Pre)
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TABLE 5. Correlations between changes in plasma protein levels of C-reactive protein
(CRP) or interleukin-6 (IL-6) and changes in body composition.
Summary of correlations between changes in plasma protein levels of C-reactive protein (CRP)
or interleukin-6 (IL-6) and changes in body fat percentage, changes in body fat, or changes in
lean body mass (LBM) percentage. CON, active control group; RT, resistance training group.
Values reported are the correlation coefficient (top), P value (bottom). * denotes significance.

Treatment Group

Change in
Body Fat Change in Change in
%
Body Fat
LBM %

Correlation
Variables
Change in plasma
CRP levels

Change in plasma
IL-6 levels

Correlation Variables

CON

0.00011,
0.9693

0.00023,
0.9559

0.001763,
0.8773

RT

0.2749,
0.0371*

0.2625,
0.0425*

0.2496,
0.0488*

CON

0,

0.01379,
0.6535

0.0006046,
0.9254

RT

0.4269,
0.0061*

0.4298,
0.0058*

0.3758,
0.0116*

3.4 Discussion
Exercise is an easily manipulated and well studied form of therapy for many chornic
diseases, such as T2D, atherosclerosis, CVD, osteoporosis and cancer. While several studies
focus on the inflammatory pathways induced acutely after an exercise bout, here we explore the
response of MC1R and MC3R on monocytes to repeated, chronic bouts of RT in an effort to
propose a novel role for the melanocortin receptors in affecting anti-inflammatory exerciseinduced responses. My results are the first to show that chronic RT does affect the protein
expression levels of MC1R and MC3R on systemic monocytes. While RT increases the number
of cells expressing MC1R, indicating an increase in the anti-inflammatory capacity of the cells to
stimuli, it decreases the number of cells expressing MC3R. One possible explanation for these
conflicting results in MCR protein expression may be that the increase in MC1R may be a
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mediating factor in the dowregulation of MC3R expression. Alternatively, exercise-induced
decreases in MC3R cell surface expression may be compensated for by MC1R upregulation,
allowing for the possible increase in anti-inflammatory processes within the monocyte.
Interestingly, my data show that smaller decreases in MC3R expression per monocyte are
significantly correlated with larger decreases in the percentage of monocytes expressing MC3R.
Thus, the increases in the percentage of cells expressing MC1R may manifest anti-inflammatory
effects in conjunction with the smaller decreases in MC3R expression per cell, where cells
expressing MC1R may express less MC3R and vice versa. Although MC1R and MC3R have
redundant immunomodulatory roles in monocytes, they may have alternate mechanisms for
activation and translocation to the plasma membrane. For example, MC1R and MC3R bind to
differing agonists and antagonists with differing affinities and upon stimulation with agonist,
MC1R and MC3R may then translocate from the plasma membrane to vesicle by endoytosis,
ultimately leading to changes in gene regulation [235-237].
As the current study measures only cell surface expression of MC1R and MC3R, there
may be intracellular changes in protein expression not noted here that may also help to explain
decreases in cell surface MC3R expression. Exercise training may increase the reservoirs of
MC3R within vesicles in the monocyte when immune cells are stimulated with pro-inflammatory
cytokines, and are released acutely after an exercise bout, allowing for a greater induction of
gene transcription. In this scenario, MCR agonists such as POMC or ACTH are secreted acutely
during and after a RT bout and act either in an autocrine or paracrine manner on the monocytes.
MC3R may then translocate to the membrane of the monocyte in an acute manner where
activation can occur. Hence, the monocyte can respond acutely to increase MC3R cell surface
expression and sensitize the cell to produce a faster and larger anti-inflammatory response.
Because the change in MC3R expression may occur acutely and may be transient in nature,
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chronic, resting plasma samples obtained at 72 hours after the last RT bout may not have
captured the complete nature of MC3R cell surface expression. This hypothesis seems plausible
as my previous study examining MC3R mRNA expression 24 hours after a resistance training
bout show significantly increased MC3R in participants undergoing a 12 week RT intervention
(unpublished data). Additional support for this hypothesis lies in the expression of MC1R and
MC3R on individual monocytes. My data show that both MC1R and MC3R cell surface
expression, when explored on individual monocytes, actually decreases in response to RT. Thus,
although a greater or lesser number of monocytes express MC1R and MC3R, respectively, all
monocytes that express each receptor possess a lower abundance of each receptor. There is a
time-dependent decreased in MC3R plasma protein density in both RT and CON but the
decrease in MC3R in CON showed no effect from treatment, while the decrease in MC3R
receptor density was dependent on the treatment (RT). Thus, the time dependent decreases seen
in MC3R may be due to seasonal variation in temperature and photoperiod, leading to
differences in receptor expression. Indeed, several studies show that MC3R exhibits circadian
rhythms and helps maintain circadian rhythms of several other genes in hepatocytes [238-239].
In addition to possible seasonal variation in MC3R, studies also show seasonal variation in IL10, which may also explain the decreases in IL-10 in both CON and RT as a function of time,
although only the decreases in IL-10 were also significantly impacted by treatment (RT) [240]. It
is also possible that seasonal changes in MC3R expression in monocytes are responsible for the
seasonal variation seen in IL-10, as stimulation of MC3R leads upregulation and secretion of IL10 from monocytes [7] and MC3R expression in hepatocytes is needed to maintain circadian
rhythms of several proteins involved in metabolism [228-229].
I also note that changes in MC1R and MC3R expression coincide with changes in
systemic cytokine expression. Here, IL-6 increases, although not significantly, in response to RT
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while IL-10 decreases. The present data is in agreement with previous studies that have noted no
change in IL-6 at the 72 hour time point but is in disagreement with previous findings for IL-10
which show increases or no change in IL-10 chronically in response to exercise [17, 46, 241242]. As my main goal in the present study was to determine chronic changes in MCR
expression in resting plasma samples, I chose the 72 hour time point to ensure that acute changes
in receptor expression would not confound the results. For example, Langberg et al 2002 show
that 180 mins of running at steady pace acutely upregulates IL-6, and IL-6 levels return to
baseline levels at 48 hours after the running bout [241]. Croisier shows that IL-6 increases
acutely after 30 maximal eccentric contractions of the knee flexor and extensor, and these levels
return to baseline 48 hours after the resistance training bout [46]. Hirose et al 2004 also report
the return of IL-6 and IL-10 levels to baseline levels by 24 hours post, following 6 sets of 5
eccentric contractions of the elbow flexors [17]. Margeli et al 2005 also show IL-6 returning to
baseline by 48 hours after an ultradistance endurance race [243]. Conversely, others, such as
Markovitch et al 2008 show no change in IL-6 or IL-10 during or after a bout of treadmill
walking at an intensity of 50% VO2max [242]. It is interesting to note that MC3R and MC1R,
both known anti-inflammatory receptors, decrease in response to RT in agreement with the
changes in IL-10 expression, where IL-10, an anti-inflammatory cytokine, decreases. Thus, it is
possible that the 72 hour time point may still contain the manifestations of the acute response to
the last bout of RT training.
Although my samples exhibit changes in MCR and cytokine expression that favor a proinflammatory rather than anti-inflammatory response at the 72 hour time point, CRP tends to
decrease (P = 0.2641) in response to RT. CRP is a much more stable marker of chronic
inflammation than more transient cytokine levels and has recently gained acceptance in the
medical community as a marker of CVD. Exercise has been shown to decrease CRP [38, 17478

177]. Thus, I believe that the overall decrease in CRP in the resistance training group may be a
consequence of the acute changes seen here. For example, changes in MCR expression may elicit
sufficient changes in cytokines or other factors that impact CRP levels, leading to its chronic
downregulation. Acute upregulation of pro-inflammatory cytokine, IL-6 has been shown to
directly upregulate transcription factors, such as C/EBP, that then upregulate CRP expression.
Others have shown that, with exercise training, downregulation of IL-6 occurs chronically
possibly due to upregulation of IL-10 [7, 75]. In conjunction with previous reports, the lack of
change seen in IL-6 in the current project coincides with the lack of a significant change in CRP
levels. However, those individuals in RT expressing higher baseline levels of CRP did
significantly decrease their CRP while no changes were seen in CON individuals expressing
higher baseline CRP levels. Furthermore, CRP levels in RT but not CON decreased from a
moderate risk category for CVD (1-3 mg/mL) to a low risk category for CVD (<1 mg/mL),
indicative of decreases in chronic inflammation possibly due to acute changes in cytokines not
represented in the present data.
Studies have noted that changes in inflammation may be dependent on changes in
adiposity, as increased percent fat correlates with increased inflammation [244]. Indeed, obesity
is a disease state that is considered to be a type of low-grade chronic inflammation [245]. Here, I
show that RT significantly decreases body fat percentage. Interestingly, changes in MC3R
negatively correlate with changes in adiposity, where individuals losing the highest percentage of
body fat also show the smallest decreases in the percentage of monocytes expressing MC3R. The
role of the MC3R in the development of obesity has been studied extensively in rodent models,
mainly in MC3R KO mice. Studies focus on the role of MC3R in the CNS, but little has been
published on the effects of MC3R in peripheral tissues on adiposity. MC3R KO mice have been
shown to exhibit increased adiposity despite hypophagia in comparison to wild type mice [87-88,
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139]. Additionally, the adipose tissue of obese MC3R KO show decreased macrophage
infiltration [87]. These previous studies indicate that peripheral MC3R expression on
macrophages mediates macrophage activation and recruitment to sites of inflammation. Based on
our current knowledge of the MC3R, one would expect that a decrease in adiposity and
inflammation would correlate with increased MC3R expression on monocytes, and my data here
supports this hypothesis. Again, I propose that while MC3R expression is decreased on the
plasma membranes of systemic monocytes obtained from resting plasma samples, MC3R protein
may be increased inside the monocyte where it resides in vesicles until stimulation. MC1R
expression, on the other hand, did not correlate with changes in adiposity.
In support of the idea that changes in inflammation are partially related to changes in
body composition, the current study also shows that changes in body composition correlate to
changes in circulating IL-6 and CRP protein levels but not IL-10 protein levels. Larger decreases
in body fat percentage and body fat are directly correlated with larger decreases in CRP and
increases in IL-6. Conversely, larger gains in LBM percentage also correlated with larger
decreases in CRP and increases in IL-6. Because IL-6 is both a cytokine and a myokine, it is not
surprising that IL-6 is somewhat elevated in response to increases in lean body percentage in the
present study [181]. It is possible that the increases in acute levels of IL-6 in response to muscle
contraction may then lead to the larger decreases in circulating levels of CRP.
In addition to changes in MC3R correlating with changes in adiposity, MC3R was also
negatively correlated with changes in resting metabolic rate, with participants experiencing the
largest increases in resting metabolic rate also showing the smallest decreases in the percentage
of monocytes expressing MC3R. These results are not surprising, as it has been discussed in
several earlier publications that the intensity and duration of an exercise bout affects changes in
metabolism and these changes in metabolism may lead to alterations in the inflammatory profile
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[246]. Based on the body composition changes in the present study, the high metabolic demand
placed on the participants as a result of our progressive, intense resistance training plan may be a
leading cause of alterations in MC3R expression and, ultimately, monocyte activation and
changes in cytokine production and secretion. Indeed, I did observe significant correlations
between the changes in the number of monocytes expressing MC3R but not MC1R and changes
in body composition. This data may further support the hypothesis that while both MC1R and
MC3R possess similar properties such as the same agonists and downstream anti-inflammatory
effects upon stimulation, there may be alternate mechanisms of activation and expression for
each receptor on systemic monocytes.
In summary, my data shows that 12 weeks of RT leads to changes in the number of
monocytes expressing MC1R and MC3R, as well as the amount of each receptor being expressed
on individual monocytes. To my knowledge this is the first investigation to study the expression
of MC1R and MC3R on systemic monocytes as a novel exercise-induced anti-inflammatory
receptor. Future studies should focus on measurement of the MCRs at various time points after a
resistance training bout in trained and untrained individuals and correlations in MCR expression
with cytokine expression. Exploration into the percent of intracellular versus plasma membrane
expression MC1R and MC3R protein also bears merit.
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CHAPTER 4. GENERAL SUMMARY
4.1 Summary
The findings in the present study for RMR and strength gains in response to the RT plan
are consistent with those found in other studies utilizing a young, healthy population as well as
some diseased populations [247-249], thus I believe that the training plan was not a limitation in
the present study. While some laboratories have reported larger increases in strength gains in
response to resistance training than the present study, these publications did not utilize an
acclimation period and measurement of strength was not completed using free weights and as in
the present study; furthermore, strength assessment may have also been performed previously for
small muscle groups. For example, Flynn et al. show that 10 wks of resistance training leads to a
34% strength increase in leg extension and a 50% in plantar flexion in 1RM assessments [250].
Frontera et al show that 12 wks of resistance training in men leads to a 116.7% increase in knee
extensor strength and 226.7% increase in knee flexor strength using 1RM assessments on a
Cybex, a pneumatic machine [251]. Both studies, as well as most resistance training intervention
studies, utilize a guided machine for each lift and assess strength in a more isoloated manner than
the testing utilized in the present study. Here we used unassisted barbell bench press and squat
for the 8RM testing which requires not only the strength to move the load but also stabilization
of the load during the lift and muscle synergy, making it more difficult than machine assisted
lifts. Furthermore, both the CON and RT groups in the present study underwent a 4 day
acclimation period including the lifts used for the 8RM assessment before the intervention
period. No acclimation period was utilized in the other aforementioned studies [250-251]. The
acclimation period may explain the smaller changes seen in strength gains in the RT group, as it
provided familiarization with the weight equipment as well as increased confidence in the CON
and RT groups in the particular lifts used during the 8RM testing. Indeed, it has been shown that
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at least 3-4 familiarization sessions with weight lifting are needed to accurately assess 1RM
measurements in young subjects [252]. Furthermore, the present study utilized an 8RM protocol
as a more accurate assessment of strength changes than a 1RM protocol, as the repetition range
for a single set in the RT regimen was usually between 8-10 repetitions. The comparison of 8RM
measurements to 1RM measurements is not a fair comparison, as derivation of an individual’s
1RM from 8RM testing is only an estimate of the 1RM due a nonlinear association between the
two. Although the changes in strength reported here are small to moderate, we do see large
increases in LBM, a 1.45kg average increase, and decreases in percent fat, 1.56% decrease, in
response to the undulating periodization utilized in the present study compared to other studies
utilizing a progressive resistance training routine in a young, healthy population. For example,
Poehlman et al. show that 6 months of progressive resistance training leads to no change in FM
and a 2kg increase in LBM [253], and, in a separate study, 6 months of RT leads to no change in
FM and a 1.3kg increase in LBM [247]. Rakobowchuk et al report a significant increase of 2.3lb
in FM and a 3.5% increase in LBM [254]. The changes in body composition seen herein are
indicative of an intense resistance training regimen that decreased the chance of habituation to
the exercise stressor. In addition to determining the effects of RT in young, healthy individuals
on RMR and strength, I set out to determine the following:
Specific Aim 1: Determine MC1R and MC3R expression and density on plasma membranes of
circulating monocytes in response to chronic, repeated resistance training bouts.
Conclusion: MC1R and MC3R cell surface expression change in response to resistance training.
The percentage of systemic monocytes expressing MC1R significantly increased in response to
RT whereas the percentage of monocytes expressing MC1R in the CON group did not change.
Conversely, the percentage of monocytes expressing MC3R significantly decreased in RT with
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no change in CON. Additionally, MC1R and MC3R plasma density decreased in RT with no
change in MC1R MFI in CON.
Specific Aim 2: Determine if resistance training alters CRP levels in conjunction with changes
in pro and anti-inflammatory cytokine profiles in college aged individuals.
Conclusions: CRP levels decreased from the moderate risk category (1-3 mg/mL) to the low risk
category (<1 mg/mL) in RT but not CON individuals, although the decrease in CRP was not
significantly different in POST RT compared to PRE RT. However in RT, CRP levels
significantly decreased POST in those individuals expressing higher baseline levels of CRP. RT
participants also experienced no chane in IL-6 and significant decreases in IL-10 in conjunction
with the changes in CRP. Concominant decreases in IL-10 were also noted in CON. Thus,
changes in IL-10 may be due to seasonal variation rather than treatment.
Specific Aim 3: Determine if MC1R and MC3R expression correlates to changes in the
inflammatory profile in college-aged individuals in response to resistance training.
Conclusions: There were no correlations between changes in MCR expression or the percentage
of monocytes expressing MCR with changes in representative cytokine or CRP expression.
There were, however, significant correlations between increases in the percentage of monocytes
expressing MC3R but not MC1R and decreases in body fat percentage and increases in lean
body mass percentage. Changes in the percentage of monocytes expressing MC3R but not
MC1R may be dependent on changes in body composition.
4.2 Conclusions
MC1R did not correlate to changes in body composition or energy expenditure in RT,
whereas changes in MC3R correlated with changes in body fat percentage, changes in body fat,
and changes in energy expenditure. Additionally, changes in MCRs did not correlate to changes
in cytokines. However, changes in both CRP and IL-6 correlated with changes in body fat
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percentage, changes in body fat, and changes in lean body mass but not changes in energy
expenditure. Changes in IL-10 did not correlate with changes in body composition or energy
expenditure. Changes in CRP did not correlate with changes in either IL-6 or IL-10.
Limitations
There are several limitations to the current study worth mentioning, including the time
point at which samples were obtained, cell surface vs. intracellular expression of MCR,
cytokines measured, and the sample population used. For example, my previous findings show
that resistance training increases MC3R mRNA expression 13-fold in whole blood samples in
older overweight women. In the current study, in an effort to avoid the effects of antiinflammatory drug use in the older population, I proposed to examine the expression of MC3R in
healthy, younger individuals, both men and women, with exercise training. Thus, I may not have
observed the same changes in protein expression due to the difference in study population.
However, I did observe a significant change in all principle outcome variables indicating that
resistance training can influence the inflammatory profile of this population. Additionally, the
inclusion of measurements of MC1R and MC3R mRNA or intracellular protein levels may have
added significance to the current study, and allowed a better comparison to the findings of my
previous study in the older postmenopausal women. I also chose the most widely measured
cytokines in exercise science, Il-6 and IL-10, as representative cytokines for changes in pro- or
anti-inflammatory pathways, respectively. The inclusion of additional cytokines may have added
more significance to our finds. Also, the measurement of MCR expression at different time
points would have allowed us to determine if the effects of the resistance training plan in the
current study shifted the time at which systemic cytokine and MCR monocyte expression return
to baseline levels.
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APPENDIX 1. PROGRESSIVE RESISTANCE TRAINING ROUTINE

ACC1
Exercise
Bench press
Bent over rows
Shoulder Press
Straight bar curls
Dumbell shrug
Pressdowns

Reps
12
12
10
10
10
10

Rest
1.5
1.5
1.5
1.5
1.5
1.5

Crunches
Crunches
Crunches
ACC2

15
12
10

1
1

Exercise
Squats
Deadlift
Walking lunges
Extensions
Lying leg curls

Reps
15
15
15
12
12

Rest
1.5
1.5
2
1.5
1.5

Standing calves
Seated calves
ACC3

10
10

1.5

Exercise
Bench press
Bench press

Reps
12
10

Rest
1.5
2

Bent over rows
Bent over rows

12
10

1.5
2

Exercise
Bench press
Bench press
Bench press

Reps
12
10
8

Rest
1.5
1.5
2

Bent over rows
Bent over rows
Bent over rows

12
10
8

1.5
1.5
2

Shoulder Press
Shoulder Press
Shoulder Press

10
8
6

1.5
1.5
2

Straight bar curls
Straight bar curls
Straight bar curls

10
8
6

1.5
1.5
2

Dumbell shrug
Dumbell shrug
Dumbell shrug

10
8
6

1.5
1.5
2

Pressdowns
Pressdowns

10
8

1.5
1.5

Shoulder Press
Shoulder Press

10
8

1.5
2

Straight bar curls
Straight bar curls

10
8

1.5
2

Dumbell shrug
Dumbell shrug

10
8

1.5
2

Pressdowns
Pressdowns

10
8

1.5
2

Crunches
Crunches
Crunches
ACC4

15
12
10

1
1

Exercise
Squats
Squats
Deadlift
Deadlift
Walking lunges
Walking lunges
Extensions
Extensions
Lying leg curls
Lying leg curls

Reps
15
12
15
12
15
12
15
12
12
10

Rest
1.5
2
1.5
2
1.5
2
1.5
2
1.5
2

Standing calves
Standing calves
Seated calves
Seated calves

12
10
12
10

1.5
2
1.5

Exercise
Squats
Squats
Squats
Deadlift
Deadlift
Deadlift
Walking lunges
Walking lunges
Walking lunges
Leg extensions
Leg extensions
Leg extensions
Lying leg curls
Lying leg curls
Lying leg curls

Reps
15
12
10
10
8
6
16
12
10
18
15
12
12
10
8

Rest
1.5
1.5
2
1.5
1.5
2
1.5
1.5
2
1.5
1.5
2
1.5
1.5
2

Standing calves
Standing calves
Standing calves
Seated calves
Seated calves
Seated calves

12
10
8
12
10
8

1.5
1.5
2
1.5
1.5

Week 3

104

Pressdowns

6

2

Crunches
Crunches
Crunches

20
15
12

1
1

Week 4
Exercise
Bench press
Bench press
Bench press
Incline press
Incline press
Incline press
inlcine push up
incline push up

Reps
10
8
6
10
8
6
15
15

Rest
1.5
1.5
2
1.5
1.5
2
1.5
2

1.5
1.5
2
1.5
1.5
2

Exercise
Squats
Squats
Squats
Squats
Deadlifts
Deadlifts
Deadlifts
Walking lunges
Walking lunges
Walking lunges
Extensions
Extensions
Extensions
Lying leg curls
Lying leg curls
Lying leg curls

Reps
12
10
8
6
8
6
4
18
15
12
10
8
6
10
8
6

Rest
1.5
1.5
1.5
2
1.5
1.5
2
1.5
1.5
2
1.5
1.5
2
1.5
1.5
2

Shoulder press
Shoulder press
Shoulder press
Lateral raises
Lateral raises
Lateral raises
Rear delt rows
Rear delt rows
Rear delt rows

10
8
6
8
8
8
10
8
6

1.5
1.5
2
1.5
1.5
2
1.5
1.5
2

25
25

1
1

Standing calves
Standing calves

10
8

1.5
1.5

10

Crunches

25

2

Standing calves

6

2

1.5

Elbow to knee

20

1

Seated calves

30

1.5

8
10
8

2
1.5

Elbow to knee
Elbow to knee

20
20

1

Seated calves
Seated calves

25
20

1.5
1.5

Exercise
Bench press
Bench press
Bench press
Incline press
Incline press
Incline press
incline push up
incline push up

Reps
10
8
6
10
8
6
15
15

Rest
1.5
1.5
2
1.5
1.5
2
1.5
2

swimmer press
swimmer press
swimmer press
isometric DB T hold135
isometric DB T hold90
isometric DB T hold45
Rear delt rows
Rear delt rows
Rear delt rows
isometric DB T hold-

10
8
6

1.5
1.5
2

Exercise
Seated rows
Seated rows
Seated rows
Back extensions
Back extensions
Back extensions
close grip pulldowns
close grip pulldowns
wide grip pulldowns
wide grip pulldowns

Reps
10
8
6
20
15
12
12
10
10
8

Rest
1.5
1.5
2
1.5
1.5
2
1.5
2
1.5
2

Straight bar curls

10

1.5

Exercise
Squats
Squats
Squats
Squats
Deadlifts
Deadlifts
Deadlifts
Walking lunges
Walking lunges
Walking lunges
Extensions
Extensions

Reps
12
10
8
6
8
6
4
18
15
12
10
8

Rest
1.5
1.5
1.5
2
1.5
1.5
2
1.5
1.5
2
1.5
1.5

30sec

0

Straight bar curls

8

1.5

Extensions

6

2

30sec

0

Straight bar curls

6

2

Lying leg curls

10

1.5

30sec
10
8
6
30sec

1
1.5
1.5
2
0

Hammer curls
Hammer curls
Hammer curls

10
8
6

1.5
1.5
2

Lying leg curls
Lying leg curls

8
6

1.5
2

Crunches

25

1

Standing calves
Standing calves

10
8

1.5
1.5

Overhead DB
extension
Overhead DB
extension
Overhead DB
extension
Pressdowns
Pressdowns

Exercise
Seated rows
Seated rows
Seated rows
Back extensions
Back extensions
close grip pulldowns
close grip pulldowns
wide grip pulldowns
wide grip pulldowns

Reps
10
8
6
20
15
12
10
10
8

Rest
1.5
1.5
2
1.5
1.5
1.5
2
1.5
2

Straight bar curls
Straight bar curls
Straight bar curls
Hammer curls
Hammer curls
Hammer curls

10
8
6
10
8
ø

Crunches
Crunches

1.5

8

Week 5

105

135
isometric DB T hold90
isometric DB T hold45
Overhead DB
extension
Overhead DB
extension
Overhead DB
extension
Pressdowns
Pressdowns

30sec

0

Crunches

25

1

Standing calves

6

2

30sec

1

Crunches
Elbow to knee

25
20

2
1

Seated calves
Seated calves

30
25

1.5
1.5

10

1.5

Elbow to knee

20

1

Seated calves

20

8

1.5

Elbow to knee

20

8
10
8

2
1.5

Reps
20

Rest
0.5

15
10
8
6
20

0.5
1.5
1.5
2
0.5

15
10
8
6
20

0.5
1.5
1.5
2
0.5

15
12

0.5
1.5

Week 6
Exercise
medicine ball throws

Reps
30

Rest
0.5

Exercise
T bar row

Reps
12

Rest
1

Dumbell press
Dumbell press
Dumbell press
medicine ball throws
decline push ups

10
8
6
30
15

1
1
2
0.5
1

T bar row
T bar row
Stiff legged deadlifts
Back extensions
Close grip pulldowns

10
8
12
30
12

1
2
1
1
1

decline push ups
Cable crossovers
Cable crossovers

12
12
10

2
1
2

Close grip pulldowns
Close grip pulldowns
Stiff legged deadlifts
Back extensions

10
8
10
25

2
2
1
1

Close grip bench press

10

1

Close grip bench press
Close grip bench press
overhead medicine ball
tosses
Lying tricep extension
Lying tricep extension
overhead medicine ball
tosses

8
6

1
2

10
8

1
1

25
10
10

0.5
1
1

25
10
8

0.5
1
2

2 box jump
cross the river
step ups

15
10
10

0.5
0.5
1.5

25

0.5

swimmer press
swimmer press

10
8

1.5
1.5

Dumbell curls
Dumbell curls
underhand medicine
ball toss
incline dumbell curl
incline dumbell curl
underhand medicine
ball toss
Concentration curls
Concentration curls

Exercise
jump squats
side leg jump
holds
squats on plank
squats on plank
squats on plank
jump squats
side leg jump
holds
side step squats
side step squats
side step squats
jump squats
side leg jump
holds
step ups

25
12
12

0.5
1.5
2

2 box jump
cross the river
step ups

15
10
8

0.5
0.5
1.5

swimmer press

6

2

Butterfly crunches

40

1

30

1

isometric DB T hold-135

30sec

0

Butterfly crunches

30

1

30

1

isometric DB T hold-90

30sec

0

Butterfly crunches

30

1.5

isometric DB T hold-45
front raises
front raises
front raises
isometric DB T hold-135
isometric DB T hold-90
isometric DB T hold-45

30sec
10
8
6
30sec
30sec
30sec

1
1.5
1.5
2
0
0
1

medicine ball twist
medicine ball twist
medicine ball twist
scissors
scissors
scissors

30
25
20
40
30
30

1
1
1
1
1.5

Exercise

Reps

Rest

one legged
standing calves
one legged
standing calves
one legged
standing calves
one legged
standing calves
seated calve raises
seated calve raises
seated calve raises
seated calve raises

25

1

50
30
30
25
50

2
1
1
1
2

Exercise

Reps

Rest

Week 7

Exercise

Rep
s

Rest
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medicine ball throws

30

0.5

T bar row

12

1

1
1

jump squats
side leg jump
holds
squats on plank
squats on plank
squats on plank
jump squats
side leg jump
holds
side step squats
side step squats
side step squats
jump squats
side leg jump
holds
step ups

Dumbell press
Dumbell press
Dumbell press
medicine ball throws
decline push ups

10
8
6
30
15

1
1
2
0.5
1

T bar row
T bar row
Stiff legged deadlifts
Back extensions
Close grip pulldowns

10
8
12
30
12

1
2
1
1
1

decline push ups
Cable crossovers
Cable crossovers

12
12
10

2
1
2

Close grip pulldowns
Close grip pulldowns
Stiff legged deadlifts
Back extensions

10
8
10
25

2
2
1
1

Close grip bench press

10

1

Close grip bench press
Close grip bench press

8
6

1
2

10
8

overhead medicine ball tosses
Lying tricep extension
Lying tricep extension

25
10
10

0.5
1
1

Lying tricep extension

8

2

Front raises
Front raises

12
10

1
1

Dumbell curls
Dumbell curls
underhand medicine
ball toss
incline dumbell curl
incline dumbell curl
underhand medicine
ball toss
Concentration curls
Concentration curls

Front raises

8

2

Upright rows

10

Upright rows
rear delt cable pulls
rear delt cable pulls
rear delt cable pulls

25
10
8

0.5
1
2

25
12
12

0.5
1.5
2

Butterfly crunches

40

1

1

Butterfly crunches

30

1

8

2

Butterfly crunches

30

1.5

12
10
8

1
1
2

medicine ball twist
medicine ball twist
medicine ball twist
scissors
scissors
scissors

30
25
20
40
30
30

1
1
1
1
1.5

20

0.5

15
10
8
6
20

0.5
1.5
1.5
2
0.5

15
10
8
6
20

0.5
1.5
1.5
2
0.5

15
12

0.5
1.5

2 box jump
cross the river
step ups

15
10
10

0.5
0.5
1.5

2 box jump
cross the river
step ups

15
10
8

0.5
0.5
1.5

30

1

30

1

25

1

50
30
30
25
50

2
1
1
1
2

one legged
standing calves
one legged
standing calves
one legged
standing calves
one legged
standing calves
seated calve raises
seated calve raises
seated calve raises
seated calve raises

Week 8
Exercise
push ups
lawnmowers

Reps
20
12

Rest
0
0

Exercise
Curl and Press
pushdowns

Reps
12
12

Rest
0
0

Exercise
Squats
walking toe lunges

Reps
30
20

Rest
0
0

military push ups
wide grip pulldowns

15
12

0
0

Straight bar curls
switch grip kickbacks
lateral raises

12
12
10

0
0
0

run stance squats
step ups

30
25

0
0.5

decline push ups
underhand pulldowns

20
12

0
0

0
0

0
0

0
0
0

30
20

18
10

12
10
12

Squats
walking toe lunges

side step pushups
close grip pulldowns

hold and curl
skull crushers
upright rows

run stance squats
step ups

30
25

0
0.5

triangle pushups

16

0

pronating curls
skull crushers

10
10

0
0

1min

0.1

25

0

seated rows

8

0

upright rows

12

0.5

wall squat
one legged
touches

push ups
lawnmowers

20
10

0
0.5

hold and curl
standing kickbacks
seated straight and leaning
shoulder flyes

10
10

0
0

one legged wall
squat
lunge and kick

1min
15

1.5
0

12

0

military push ups
wide grip pulldowns

15
15

0
0.5

Curl and Press

12

0

wall squats
one legged

1min
25

0.1
0.5
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floor

floor

touches
pushdowns
decline push ups
underhand pulldowns

20
12

0
0.5

side step pushups

18

0

close grip pulldowns

10

12

Straight bar curls
switch grip kickbacks
lateral raises

0

12
12
10

0
0
0

0.5

triangle pushups

16

0

seated rows

8

0.5

holds
holds
holds
frog

1min
1min
30sec
30

0
0
0
0

one leg holds
one leg holds
scissors
reach and cross toe touch
fist twists

1min
1min
30
50
50

0
0
0
0
0

Exercise
medicine ball throws
Dumbell press
Dumbell press
Dumbell press
medicine ball throws
decline push ups
decline push ups
Cable crossovers
Cable crossovers

Reps
30
10
8
6
30
15
12
12
10

Rest
0.5
1
1
2
0.5
1
2
1
2

Close grip bench press
Close grip bench press
Close grip bench press
overhead medicine ball
tosses
Lying tricep extension
Lying tricep extension
overhead medicine ball
tosses

10
8
6

1
1
2

25
10
10

0.5
1
1

25

0.5

swimmer press
swimmer press

10
8

1.5
1.5

swimmer press

6

2

isometric DB T hold-135

30sec

isometric DB T hold-90
isometric DB T hold-45
front raises
front raises
front raises
isometric DB T hold-135
isometric DB T hold-90
isometric DB T hold-45

pronating curls
standing kickbacks
seated straight and leaning
shoulder flyes

10
10

0
0

12

0

one legged wall
squat
lunge and kick

1min
15

1.5
0

1min

0.1

25

0.5

holds

1min

0

holds
holds
frog
one leg holds
one leg holds
scissors
reach and cross toe
touch
fist twists

1min
30sec
30
1min
1min
30

0
0
0
0
0
0

50
50

0
0

Reps
20
15
10
8
6
20
15
10
8
6
20
15
12

Rest
0.5
0.5
1.5
1.5
2
0.5
0.5
1.5
1.5
2
0.5
0.5
1.5

wall squat
one legged
touches

floor

Week 9
Exercise
T bar row
T bar row
T bar row
Stiff legged deadlifts
Back extensions
Close grip pulldowns
Close grip pulldowns
Close grip pulldowns
Stiff legged deadlifts
Back extensions

Reps
12
10
8
12
30
12
10
8
10
25

Rest
1
1
2
1
1
1
2
2
1
1

Dumbell curls
Dumbell curls
underhand medicine ball
toss
incline dumbell curl
incline dumbell curl
underhand medicine ball
toss
Concentration curls
Concentration curls

10
8

1
1

Exercise
jump squats
side leg jump holds
squats on plank
squats on plank
squats on plank
jump squats
side leg jump holds
side step squats
side step squats
side step squats
jump squats
side leg jump holds
step ups

25
10
8

0.5
1
2

2 box jump
cross the river
step ups

15
10
10

0.5
0.5
1.5

25
12
12

0.5
1.5
2

2 box jump
cross the river
step ups

15
10
8

0.5
0.5
1.5

Butterfly crunches

40

1

30

1

0

Butterfly crunches

30

1

30

1

30sec

0

Butterfly crunches

30

1.5

25

1

30sec
10
8
6
30sec
30sec
30sec

1
1.5
1.5
2
0
0

medicine ball twist
medicine ball twist
medicine ball twist
scissors
scissors
scissors

30
25
20
40
30
30

1
1

50
30
30
25
50

2
1
1
1
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1
1

one legged standing
calves
one legged standing
calves
one legged standing
calves
one legged standing
calves
seated calve raises
seated calve raises
seated calve raises
seated calve raises

Week 10
Exercise
medicine ball throws
Dumbell press
Dumbell press
Dumbell press
medicine ball throws
decline push ups
decline push ups
Cable crossovers
Cable crossovers

Reps
30
10
8
6
30
15
12
12
10

Rest
0.5
1
1
2
0.5
1
2
1
2

Close grip bench press
Close grip bench press
Close grip bench press
overhead medicine ball
tosses
Lying tricep extension
Lying tricep extension
overhead medicine ball
tosses

10
8
6

1
1
2

25
10
10

0.5
1
1

25

0.5

swimmer press
swimmer press

10
8

1.5
1.5

swimmer press

6

2

isometric DB T hold-135

30sec

isometric DB T hold-90
isometric DB T hold-45
front raises
front raises
front raises
isometric DB T hold-135
isometric DB T hold-90
isometric DB T hold-45

Exercise
T bar row
T bar row
T bar row
Stiff legged deadlifts
Back extensions
Close grip pulldowns
Close grip pulldowns
Close grip pulldowns
Stiff legged deadlifts
Back extensions

Reps
12
10
8
12
30
12
10
8
10
25

Rest
1
1
2
1
1
1
2
2
1
1
1
1

Exercise
jump squats
side leg jump holds
squats on plank
squats on plank
squats on plank
jump squats
side leg jump holds
side step squats
side step squats
side step squats
jump squats
side leg jump holds
step ups

Reps
20
15
10
8
6
20
15
10
8
6
20
15
12

Rest
0.5
0.5
1.5
1.5
2
0.5
0.5
1.5
1.5
2
0.5
0.5
1.5

Dumbell curls
Dumbell curls
underhand medicine ball
toss
incline dumbell curl
incline dumbell curl
underhand medicine ball
toss
Concentration curls
Concentration curls

10
8
25
10
8

0.5
1
2

2 box jump
cross the river
step ups

15
10
10

0.5
0.5
1.5

25
12
12

0.5
1.5
2

2 box jump
cross the river
step ups

15
10
8

0.5
0.5
1.5

Butterfly crunches

40

1

30

1

0

Butterfly crunches

30

1

30

1

30sec

0

Butterfly crunches

30

1.5

25

1

30sec
10
8
6
30sec
30sec
30sec

1
1.5
1.5
2
0
0

medicine ball twist
medicine ball twist
medicine ball twist
scissors
scissors
scissors

30
25
20
40
30
30

1
1

50
30
30
25
50

2
1
1
1

1
1

one legged standing
calves
one legged standing
calves
one legged standing
calves
one legged standing
calves
seated calve raises
seated calve raises
seated calve raises
seated calve raises

Week 12
Exercise
Close grip bench press
Close grip bench press
Close grip bench press
standing switch grip kickbacks
standing switch grip kickbacks
wide rope pushdowns
wide rope pushdowns

Reps
10
10
10
14
14
8
8

Rest
1
1
2
1
2
1
2

reverse cable dumbell curls
reverse cable dumbell curls
incline dumbell curl
incline dumbell curl
pronating curls
pronating curls

8
8
8
8
8
8

1
2
1
2
1
2

pullovers
pullovers

8
8

1
1

Exercise
Squats
Squats
Squats
Squats
Squats
Extensions
Extensions
Lying leg curls
Lying leg curls

Reps
15
8
6
4
2
8
8
8
8

Rest
1.5
2
2
2
2
1.5
2
1.5
2

Standing calves
Standing calves
Seated calves
Seated calves
Seated calves

8
6
30
25
20

1.5
2
1.5
1.5
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Exercise
bench press
bench press
bench press
bench press
incline press
incline press
flyes
flyes

Reps
8
8
6
6
6
6
8
8

Rest
1
2
2
2
1
2
1
2

seated rows
seated rows
seated rows
Stiff legged deadlifts
Stiff legged deadlifts
switch grip pulldowns
switch grip pulldowns
switch grip pulldowns

12
12
10
15
12
10
10
10

1
1
1
1
1
1
1

military press
military press
reverse pullovers
reverse pullovers

10
10
8
8

1
2
1
2

plank
plank
plank
medicine ball twist
medicine ball twist
medicine ball twist
leg press ups
leg press ups
leg press ups

40
30
30
30
25
20
40
30
30

0.5
0.5
1
0.5
0.5
1
0.5
0.5

Week 13
Exercise
seated calve raises
seated calve raises
seated calve raises
seated calve raises
Lying leg curls
Lying leg curls
Lying leg curls
mary catherine lunges
Extensions
Extensions
Extensions
mary catherine lunges
Squats
Squats
Squats
mary catherine lunges
Deadlifts
Deadlifts
mary catherine lunges

Reps
30
30
25
50
10
10
10
15
10
10
10
15
8
8
8
15
8
8
15

Rest
1
1
0.5
1.5
1.5
1.5
2
1.5
1.5
1.5
2
1.5
1.5
1.5
2
1.5
1.5

Exercise
bench press
bench press
bench press
bench press
bench press
incline press
incline press
flyes
flyes

Reps
15
8
6
4
2
6
6
8
8

Rest
1
2
2
2
2
1
2
1
2

seated rows
seated rows
Stiff legged deadlifts
Stiff legged deadlifts
switch grip pulldowns
switch grip pulldowns

12
10
15
12
10
10

1
1
1
1
1

Exercise
Close grip bench press
Close grip bench press
Close grip bench press
standing switch grip kickbacks
standing switch grip kickbacks
wide rope pushdowns
wide rope pushdowns

Reps
10
10
10
14
14
8
8

Rest
1
1
2
1
2
1
2

reverse cable dumbell curls
reverse cable dumbell curls
incline dumbell curl
incline dumbell curl
pronating curls
pronating curls

8
8
8
8
8
8

1
2
1
2
1
2

pullovers
pullovers
military press
military press
reverse pullovers
reverse pullovers

8
8
10
10
8
8

1
1
1
2
1
2

plank
plank
plank
medicine ball twist
medicine ball twist
medicine ball twist
leg press ups
leg press ups
leg press ups

40
30
30
30
25
20
40
30
30

0.5
0.5
1
0.5
0.5
1
0.5
0.5

Week 14
Exercise
deadlifts
deadlifts
deadlifts
deadlifts
deadlifts
deadlifts
switch grip pulldowns

Reps
15
8
6
4
2
2
10

Rest
1
2
2
2
2
2
1

Exercise
holds
holds
holds
frog
one leg holds
one leg holds
scissors

Reps
1min
1min
30sec
30
1min
1min
30
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Rest
0
0
0
0
0
0
0

Exercise
seated calve raises
seated calve raises
seated calve raises
seated calve raises

Reps
30
30
25
50

Rest
1
1
0.5

Lying leg curls
Lying leg curls

10
10

1
2

switch grip pulldowns

10

2

bench press
bench press
bench press
bench press
decline push ups
decline push ups
flyes
flyes

8
8
6
6
6
6
8
8

1
2
2
2
1
2
1
2

reach and cross toe touch
fist twists

50
50

0
0

standing switch grip kickbacks
standing switch grip kickbacks
wide rope pushdowns
wide rope pushdowns

14
14
8
8

1
2
1
2

reverse cable dumbell curls
reverse cable dumbell curls
pronating curls
pronating curls

8
8
8
8

1
2
1
2

pullovers
pullovers
military press
military press
reverse pullovers
reverse pullovers

8
8
10
10
8
8

1
1
1
2
1
2
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3 angle lunge and kick
mary catherine lunges
Extensions
Extensions
3 angle lunge and kick
mary catherine lunges
Squats
Squats
Squats
3 angle lunge and kick
mary catherine lunges
Deadlifts
Deadlifts

30
15
10
10
30
15
8
8
8
30
15
8
8

0
0
1
2
0
0
1.5
1.5
2
0
0
1.5

APPENDIX 2. PARTICIPANT CONSENT FORM
1. Study Title: Strength Training Induced Alterations in Markers of
Immune Function
2. Performance Site: Louisiana State University
Baton Rouge, LA 70803
3. Investigators: The following investigators are available for questions about this study,
M-F, 8:00 a.m.- 10:40 a.m., 1:40 p.m. - 4:30 p.m.

4.

Principal Investigator: Laura K. Stewart, Ph.D.
Co-investigator: Tara Henagan,
Purpose of the Study:

The purpose of this research project is to examine the effect of a 12 week
intensive strength training intervention on markers of immunity.
Subject Inclusion:
Participants in both the control and training groups must be at least 18 years of
age and currently enrolled as students at LSU and may not be pregnant. Students
in the training group must have medical clearance following a complete
comprehensive physical from a State licensed M.D. or D.O. The cleared student
must provide documentation of permission by returning a signed “Physician
Approval Form” after the physical and before participating in the study. Students
must complete a physical activity readiness questionnaire (PAR-Q) before
participating.
5. Number of subjects = 60 (n = 30 in the training group and n = 30 in the control group).
6. Study Procedures:
Baseline: Before the 12 week training program begins, you will have baseline
measurements taken. This will include height, weight, blood pressure, heart rate,
body composition (body fat percentage, bone mineral density) taken with a DXA
and skinfold measurements taken with a Lange skinfold caliper. At this time, you
will also fill out questionnaires. We will take a resting/fasting venous blood
sample from your antecubital vein between 6 and 9am. An assessment of your
physical fitness will be estimated by having you perform a 8RM test with blood
lactate measurements taken by finger prick every 5 minutes up to 30 minutes after
your resistance training bout.
12 Week Intervention Program: At the start of the program, you will be provided with a
suggested training program (training groups only). If you choose not to follow
this training program, you will not be penalized. Throughout the 12 week training
period, all groups will fill out a training log and a 3-day diet recall log, as well as
a sickness and injury inventory questionnaire. This should take about 20 minutes
weekly to complete. Participants in the control group will be instructed to
continue ususal day to day activities. Participants in both groups will continue to
complete weekly training and diet logs, and sickness inventory questionnaires.
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Post-Training: During the last week of class, you will undergo post-training measures.
Procedures for post-training measurements will be identical to the protocol
followed for preliminary measures.
7. Benefits:
While no guarantee of benefits can be made, you will be given training instruction
and a body composition analysis at no cost to you. You may also learn more
about your physical capacity for strength and should significantly improve your
anaerobic fitness. Subjects will be provided a comparison of his/her pre-training
and post-training results at the end of the semester.
8. Risks/Discomforts:
Exercise Training & Testing: As with any exercise program, there is a chance
that you will experience muscle soreness, fatigue, or even injuries such as sprains
or strains. There is also a remote risk of a heart attack or stroke and in very rare
cases, death. Precautions to minimize this risk have been taken by requiring
medical clearance to participate as well as completion of a health history
questionnaire. Your cooperation in obtaining approval from your physician as
well as providing honest answers in completing the health history form will
decrease this risk.
DXA: The Dual Energy X-Ray Absorptiometry test uses an x-ray technique to
assess the density of your body and can then provide an accurate estimate of body
fat percentage and lean body mass. The whole body DXA scan exposes subjects
to low levels of ionizing radiation. No discomfort will be felt during the DXA
scan. There is a risk of radiation exposure from this test, but it is well below the
level that would provide any adverse effects. The total body DXA Scan will
produce less than 0.37 µSV (0.037 mrem) of ionizing radiation skin entrance
dosage. The skin entrance dose of 0.37 µSV is well below the yearly public limit
dose for incidental exposure of 1,000 µSV (100 mrems).
Skinfold measurements: Since a slight pinching of the skin is required to measure
subcutaneous fat through calipers, you may experience mild bruising in the
measurement sites (chest, midaxillary, triceps, subscapular, abdomen, suprailiac,
and thigh).
Blood Sampling: There is a risk of bruising and a remote risk of infection with
the blood sampling techniques. You may also become lightheaded and faint
during these procedures. These risks will be minimized by having trained
technicians using sterile, single-use supplies for blood sampling. You will be
seated during blood sampling, but you should tell us if you feel dizzy or faint.
In addition to the risks listed above, you may experience a previously unknown risk or
side effect.
9. Injury/Illness:
In the unlikely event of injury or medical illness resulting from the above
procedures, contact Laura Stewart, Ph.D., 225-578-3549. You will be referred
for treatment, but the expense of medical treatment will be your responsibility. No
compensation is available in case of study-related illness or injury.
10. Right to Refuse:
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You may choose not to participate or to withdraw from the study at any
time without penalty or loss of any benefit to which you might otherwise be
entitled.
11. Privacy:
Your identity will remain confidential unless disclosure is required by law. In
other words, data will be kept confidential unless release is legally compelled.
All data collected will be handled only by the investigators and kept in a secure
location. Results of the study may be published using group means only and
names or identifying information will not be included in the publication.
12. Financial Information:
There is no cost to you, nor is there any compensation for participating in the
study.
13.

Signatures:
The study has been discussed with me and all my questions have been answered.
I may direct additional questions regarding study specifics to the investigators.
If I have any questions about subjects’ rights or other concerns, I can contact
Robert C. Matthews, Institutional Review Board at (225) 578-8692. I agree to
participate in the study described above and acknowledge the investigator’s
obligation to provide me with a signed copy of this consent form.

_____________________
______________
Participant’s Signature
Date
The study subject has indicated that s/he is unable to read. I certify that I have read this consent
form to the subject and explained that by completing the signature line above, the subject has
agreed to participate.

_____________________
Reader’s Signature
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______________
Date
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APPENDIX 4. PHYSICIAN’S APPROVAL FORM
Physician Approval Form
Kinesiology 4501
The Physiology of Endurance Training
*This physical must be completed by a State licensed M.D. or D.O. only*

I have completed a full comprehensive physical examination of _____________________ (print
student’s full name) as required for him/her to participate in Kinesiology 4501 (The Physiology
of Weight Training). I understand that the student will be engaging in an intensive resistance
training and conditioning program which will involve optional participation in a coursedesignated weight lifting routine for the Spring 2010 semester. Based on my physical findings, I
am making the following recommendation related to the demands of the course:
____ Patient is cleared to participate without restriction.
____ Patient is cleared to participate with the following restrictions or guidelines.
__________________________________________________________________
_____ Patient is not cleared to participate.
Physician Signature: _________________________________________________
Physician Name (Print):______________________________________________ _
Date: ______________________________________________________________
Address: ___________________________________________________________
Phone: ____________________________________________________________
Fax: ______________________________________________________________
Email: _____________________________________________________________
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Baton Rouge, Louisiana. After several moves as a child, Tara became a permanent resident of
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Tara graduated from St. Michael the Archangel High School in 2000. She attended Louisiana
State University with a Honors TOPS scholarship and graduated with a Bachelor of Science
degree in biological sciences with a minor in anthropology in 2004.
Upon completion of her degree program in 2004, Tara worked as a Research Assistant in
Dr. Thomas W. Gettys’ laboratory at the Pennington Biomedical Research Center, where her
appreciation of science and scientific research blossomed. While working with Dr. Gettys, Tara
met a fellow researcher and postdoctoral fellow, Dr. Laura K. Stewart. Due to their mutual
regard for scientific research, Tara followed in Dr. Stewart’s footsteps and entered the graduate
program with Dr. Stewart as her mentor in 2007. While in graduate school, Tara received the
Corbett Graduate Student Summer Fellowship and a recurring teaching assistantship in the
School of Education through the Department of Kinesiology. In 2010, Tara passed her Certified
Strength and Conditioning examination. She plans to utilize her knowledge in weight lifting to
help others achieve a healthier lifestyle. Tara plans to graduate from the graduate program at
LSU in December 2010, only three short years after joining the program, with a Doctor of
Philosophy in kinesiology and a minor in pathobiological sciences.
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